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Cell migration plays pivotal roles in both physiological and pathological 
processes; from morphogenesis during embryonic development to 
cardiovascular disorders and cancer metastasis. It is a highly dynamic process 
whereby numerous cell signaling cues are integrated to generate coordinated 
responses. This fundamental cellular function involves various regulatory 
machineries that support cells to react to diverse external stimuli. To migrate, 
cells require for the cell-generated forces to be transmitted to the extracellular 
environment through the focal adhesion complexes formed at their ventral 
surfaces in close contact with the extracellular matrix.  While a number of 
signaling proteins are localized at adhesion sites, they have been shown to 
have significant impacts on cell migration. Of those focal adhesion proteins, 
p130Cas (Crk-associated substrate, hereafter Cas) plays a critical role in many 
intracellular signaling cascades through undergoing phosphorylation and 
dephosphorylation as well as functioning as a scaffold for formation of multi-
molecular complexes. Cas has also been implicated in the regulation of cell 
migration.  
We have previously demonstrated that Cas supports cell migration 
through the association with both Src and actin cytoskeletons at focal 
adhesions. Although Cas is known to bind to Src through the Src-binding 
domain, it is unclear how Cas associates with inwardly moving actin 
filaments. Since Cas-actin association depends on the tyrosine 
phosphorylation of Cas substrate domain (CasSD), we conduct a candidate 
search for a molecule that can bind to both actin filaments and 
phosphotyrosine-containing polypeptides.  
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Tensin 1, is an actin-binding molecule that has been implicated as a 
phosphorylation-specific binding partner of Cas.  We therefore test if tensin 1 
supports cell migration by linking actin cytoskeletons to Cas with 
phosphorylated CasSD.  
Live cell confocal imaging demonstrates that tensin 1 co-localizes with 
Cas at cell lamellipodia depending on the tyrosine phosphorylation of CasSD. 
In contrast, a truncation mutant of tensin 1 that lacks SH2PTB domain is not 
recruited to the focal adhesions. The silencing of tensin 1 in mouse embryonic 
fibroblasts (MEFs) by RNA interference results in impeded cell migration.  
Expression of another truncation mutant of tensin 1 that carries only the 
phosphotyrosine-binding region, tensin 1-SH2PTB, interferes with Cas-driven 
cell migration, and extends the residence of Cas molecules at focal adhesions.  
Furthermore, bacterially expressed recombinant tensin 1-SH2PTB protein 
binds to Cas in vitro, depending on the CasSD phosphorylation.  In addition, 
we find that the treatment with a low dose (5 nM) of PAO, the tyrosine 
phosphatase inhibitor, which appears to reinforce Cas-tensin 1 association 
without affecting the actin retrograde flux, weakens Cas-Src interaction and 
retards cell migration. 
Collectively, we conclude that tensin 1 links inwardly moving actin 
cytoskeletons to phosphorylated Cas at focal adhesions, thereby supporting 
cell migration. Based on the temporal nature of Src-Cas and Cas-tensin 1 
associations, the actin-tensin 1-Cas-Src linkage could serve as a molecular 
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1.1 Cell migration 
1.1.1 The role of cell migration 
Cell migration is a complex biological process that supports or underlies vital 
functions of a diverse range of living organisms. For example, amoeba, as a 
unicellular organism, requires to migrate for food searching and mating 
(Manahan et al., 2004).  In human beings, cell migration is involved in normal 
development as well as pathological conditions and diseases including 
vascular disorder, osteoporosis, rheumatoid arthritis, and cancer (Ridley et al., 
2003). Indeed, the most life-threatening aspect of cancer is the formation of 
distant metastases which mainly result from the aberrant invasive migration of 
cells away from the primary tumor (Sahai, 2005; Sun et al., 2014; Nguyen et 
al., 2009).  
Having such significant relevance to human health, cell migration has 
been intensely studied for many years. Particularly, the past few decades have 
witnessed substantial advances in our understanding of the complexities and 
subtleties underlying the regulation of cell migration (Vicente-Manzanares et 
al., 2005). It has been recognized as a highly dynamic process that involves 
numerous cell signals to be integrated, creating a coordinated collective 
cellular movement (Meenderink et al., 2010). Interestingly, different types of 
cells exhibit dissimilar modes of migration. For instance, fibroblasts typically 
migrate by forming lamellipodia, which are the actin-rich extensions at the 
leading edge of cells (Sixt, 2012). On the contrary, leukocytes adopt different 
morphology during their migration, where amoeba-like movement and 
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morphology are exhibited. While keratocytes display a gliding motion, 
epithelial monolayers preserve cell-cell contacts during gastrulation and 
wound healing (Vicente-Manzanares et al., 2005). 
In response to a variety of migratory signals from cytokines and 
extracellular matrix (ECM) components, cell migration is initiated by a series 
of spatially regulated changes in the cytoskeleton and cell adhesions (Chen et 
al., 2013). Subtle but vibrant alterations in the structures and compositions of 
focal adhesions play important roles in both attachment and detachment of 
cells that occur in the process of migration (Lo et al., 1994). For instance, the 
migration of fibroblasts depends on the interactions between cell-surface 
adhesion receptors and components of the ECM (Choquet et al., 1997).       
 
1.1.2 The cell migration cycle 
Cell migration consists of a cyclic procedure that involves several critical 
cellular processes coordinating each other at different phases (Sheetz et al., 
1999; Lauffenburger and Horwitz, 1996; Ridley et al., 2003).  Polarization is a 
term coined to describe the initial phase of cell migration. First, a cell 
undergoes polarization when it senses environmental cues, such as wound 
healing stimuli. This initial event is then followed by the extension of 
protrusions at the leading edge of the cell. Sheet-like lamellipodia or spike-like 
filopodia extend out from the cell leading edge in the direction of the polarized 
pole. These protrusions, in which actin polymerization provides dominant 
driving forces, are then stabilized by the formation of focal adhesion 
complexes that are intimately linked to both the ECM and the actin 
cytoskeleton, serving as the traction points for migration to proceed.  In order 
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for the cell to translocate forward, adhesions at the rear need to be 
disassembled with coupled to the actomyosin contraction.  Being involved in 
the extension, development and disassembly of the protrusions/adhesions, the 
actin cytoskeleton is the key player in all aspects of the cell migration process 




The formation of leading and trailing cell edges is largely influenced by 
polarization. The signaling machinery regulating the cell polarity plays a 
major role in determining directional cell motility (Petrie et al., 2009). 
Typically, polarization is the first step in the cell migration cycle.  For cells to 
migrate, they need to acquire a spatial asymmetry which in turn enables them 
to convert intracellularly generated forces into a net cell body translocation 
(Lauffenburger and Horwitz, 1996).  Forming and sustaining the cell polarity 
leads to the development of actin polymerization at the leading lamellae 
coupled to the actomyosin-driven retraction of the trailing edge; which 
ultimately promotes directional cell migration (Petrie et al., 2009). The 
immediate consequence of polarization is the extension of active membrane 
processes, including both lamellipodia and filopodia, featuring primarily 
around the cell front (Lauffenburger and Horwitz, 1996).  
During polarization, the Par (partitioning defective) complex, which 
consists of PAR3, PAR6 and atypical protein kinase C (aPKC), links Rho 
GTPase signaling as well as centrosome reorientation, microtubule 
stabilization and membrane trafficking to the regulation of directional 
persistence needed for intrinsic cell migration. The activation of the Par 
complex polarizes a diverse range of cellular processes, including the 
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establishment of the front-rear axis in migrating cells or the basal-apical 
polarity in epithelial cells, and the asymmetric cell division (Petrie et al., 
2009). One of the Rho GTPase family members, CDC42, is a principal 
regulator of cell polarization, which determines the directional cell migration 
(Petrie et al., 2009). Activation of CDC42 upon integrin engagement then 
leads to the recruitment of the Par complex to the plasma membrane, where 
aPKC is activated. Subsequently, CDC42-dependent activation of the Par 
complex initiates the development of polarized protrusions and directionally 
persistent cell migration (Petrie et al., 2009). 
 
1.1.2.2 Protrusion 
Once cell polarity is established, the second stage of cell migration, i.e; 
protrusion ensues. There are two major types of protrusive structures, namely 
lamellipodia and filopodia (Vicente-Manzanares et al., 2009).  At the cell front, 
lamellipodia exhibit a broad, flatten sheet-like protrusive morphology whereas 
filopodia are thin, cylindrical, needle-like projections (Lauffenburger and 
Horwitz, 1996). In these structures, cytoplasmic organelles are absent, but 
abundant actin and actin-associated proteins are accumulated (Lauffenburger 
and Horwitz, 1996). In the current paradigm of cell migration, actin filaments 
polymerizing within the leading lamellipodia generate the pushing force 
required for protrusion. As the tension of the lamellipodia opposes the free 
anterograde expansion of the actin network, the filaments are pushed back 
towards the cell body, which is visible as a retrograde actin flow (Pollard and 
Borisy, 2003; Sixt, 2012). The protrusive force localized at the cell front is 
generated by a ‘treadmilling’ process in which the rapid elongation of actin 
filaments at the leading edge compensates the depolymerization directed 
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towards the cell body (Wang, 1985). The rate of actin treadmilling is 
controlled by several actin-binding proteins activities (Le Clainche and Carlier, 
2008). 
The frequency and direction of local lamellipodial protrusions are the 
two major factors that determine the orientation of cell migration (Petrie et al., 
2009). Therefore, the intracellular signaling at the leading lamellae that 
regulates the actin cytoskeleton remodeling or focal adhesion establishment to 
create or stabilize local protrusions contributes to the directional migration 
(Petrie et al., 2009). One significant element of such signals is the local 
calcium (Ca2+) concentration. Spatially restricted but transient upsurges of 
intracellular Ca2+ guide growth cone migration during haptotaxis and 
chemotaxis. Growth cone motility is mediated by the local fluxes of 
intracellular Ca2+, which in turn trigger the activation of Rac1 and CDC42 and 
the inactivation of RhoA (Petrie et al., 2009). In lamellipodia, the small 
GTPases CDC42 and Rac1 activate adaptor and/or signaling molecules of the 
Wiskott-Aldrich syndrome family of proteins such as WASP (Wiskott-Aldrich 
syndrome protein) and WAVE (WASP-family verprolin-homologous protein), 
and subsequently activate the Arp2/3 complex (Vicente-Manzanares et al., 
2009). The nucleation of actin-filament branches then ensues, resulting in a 
broad dendritic-like actin network formation (Jaffe and Hall, 2005; Pollard 
and Borisy, 2003; Vicente-Manzanares et al., 2009). As for filopodia, CDC42 
enhances linear actin polymerization with the involvement of formins and 
vasodilator-stimulated phosphoprotein (VASP), and fascin organizes 
polymerized actin into elongated filaments (Mattila and Lappalainen, 2008; 
Vicente-Manzanares et al., 2009). 
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An actin-severing protein, cofilin, or ADF (actin-depolymerizing 
factor), prompts pointed end depolymerization and promotes barbed end 
polymerization by increasing the concentration of diffuse monomeric actin 
(Carlier et al., 1999; Petrie et al., 2009). Localized activity of cofilin is 
imperative in directional cell migration. Augmented random migration is 
observed when cofilin expression is decreased in fibroblasts (Petrie et al., 
2009). In addition, lamellipodial dynamics regulated by both cofilin and the 
Arp2/3 complex is a critical factor in dictating the directional cell migration of 
these cells. Profilin, another actin-binding protein, is thought to target 
monomeric actin tobarbed ends. Combination of both cofilin and profilin 




Focal adhesions are sites of molecular interaction between the cell and the 
extracellular substrate (Vicente-Manzanares et al., 2005). Structurally defined 
adhesion complexes were initially described few decades ago using the 
interference-reflection microscopy and the electron microscopy (Zamir and 
Geiger, 2001). These studies have revealed that focal adhesions form along the 
ventral plasma membrane that are closely connected to the ECM, leaving a 
gap of only 10 to 15 nm (Zamir and Geiger, 2001). The focal adhesions 
assemble and disassemble in response to extracellular stimuli and regulate cell 
migration (Vicente-Manzanares et al., 2005). Formation of focal adhesions 
represents the integration of mechanical, biochemical, and structural cues to 
provide dynamic links between the actin cytoskeleton and the surrounding 
ECM microenvironment. This process is absolutely important in guiding cell 
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differentiation, proliferation, ECM remodeling and, cell migration (Oakes et 
al., 2012).   
During cell migration, focal adhesions assemble at the leading edge 
and disassemble at the trailing edge (Vicente-Manzanares et al., 2005). Focal 
adhesions also undergo disassembly at cell front during protrusion and feed 
components to nascent adhesions at the leading edge in a process called focal 
adhesion turnover (Webb et al., 2004; Vicente-Manzanares et al., 2005). 
Taken together, focal adhesions can either dissemble or stabilize at the 
protruding edge to continue growing into more mature, larger adhesions 
(Vicente-Manzanares et al., 2005). Generally, highly mobile cells, especially 
those in vivo, large sizes of focal adhesions are absent that characterize less 
motile cells in 2D cultures.  
For cell migration to occur, a protrusion needs to form and then 
stabilize by attaching to the surrounding ECM. Although there are many 
different adhesion molecules involved in cell migration, the integrins are still a 
major family of migration-promoting surface receptors (Ridley et al., 2003). 
These receptors are deemed as the “feet” of a migrating cell because they 
support the adhesion to the ECM or other cells. These complex multi-
molecular assemblies are linked to the termini of actin stress fibers through 
adaptor proteins (Raz-Ben Aroush et al., 2008). The integrins are 
heterodimeric receptors consisting of α and β chains.  The ligand-binding 
extracellular domains are long while their cytoplasmic domains are short 
(Ridley et al., 2003). The ligand binding to the extracellular domain of 
integrins leads to conformational changes of the receptors based on the altered 
interactions between the α- and β-chain cytoplasmic domains, which are 
followed by their clustering. This synergistic combination of occupancy and 
9 
 
clustering triggers intracellular signals. For example, the integrin activation 
enhances the activity of small GTPases, protein tyrosine phosphorylation, and 
phospholipid biosynthesis that regulate the formation and strengthening of 
adhesion sites, the organization and dynamics of the cytoskeleton, and cell 
polarity during migration (Ridley et al., 2003). Many actin- and signal 
transduction-related molecules have been reported to bind to integrins, thus 
regulating signals from integrins to the actin cytoskeleton and at the same time, 
integrin activation. A typical example of integrin-associated signaling would 
be the one related to zyxin, which binds to α-actinin and regulates the function 
of Ena/VASP on neighboring actin barbed ends (Zaidel-Bar et al., 2004). In 
the case of talin, it directly links integrins to actin and activates them (Nayal et 
al., 2004; Ridley et al., 2003). Through integrin-mediated adhesion complexes 
that couple the actin cytoskeleton to the ECM, the retrograde-directed forces, 
which are enforced by the actomyosin contraction, are translated into the 
propulsion of the cell body (Vicente-Manzanares et al., 2009). 
 
1.1.2.4 Tail retraction 
The trailing edge of a migrating cell contributes to the maintenance of 
directional migration by generating contractile forces that pull the rear of the 
cell forward and limiting the formation of protrusions to maintain the 
orientation of migration (Petrie et al., 2009). Rapid migration requires the 
efficient and coordinated disassembly of adhesions at the cell rear. The rates 
of both lamellipodial protrusion and tail retraction potentially influence the 
cell migration velocity. In some cells, the tail retraction can be the rate-
limiting step that determines the overall migration rate (Chen, 1981; 
Lauffenburger and Horwitz, 1996).  In fibroblasts, the rearmost adhesions 
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often tether the cell firmly to the ECM. Consequently, a long tail to the site of 
anchorage is observed (Ridley et al., 2003). The tension built up in the actin 
cytoskeleton is sufficient to physically disrupt the linkage to integrin, leaving 
integrin behind while the rest of the cell moves on (Ridley et al., 2003). 
High tension exerted on the rear adhesions contributes to the cell 
detachment. Increasing evidence shows that the actomyosin contraction plays 
a significant role in regulating the mechanism of cell trailing edge detachment 
as well as in the maintenance of cell polarity (Ridley et al., 2003). Particularly, 
myosin II-driven contraction is thought to be vital for the tail retraction (Petrie 
et al., 2009; Ridley et al., 2003; Lauffenburger and Horwitz, 1996). 
Actomyosin-driven tail retraction is accompanied by the release of rearmost 
adhesions at of the cell, allowing the cell body to translocate (Kirfel et al., 
2004). Dictyostelium cells deficient in myosin II show weakened retraction 
and the formation of multiple pseudopodia along the periphery of the cell. 
Two isoforms of myosin II, namely myosin IIA and IIB, are commonly 
expressed in fibroblasts. Myosin IIA depletion leads to the formation of broad 
lamellipodia, increased Rac1 activaty and cell random migration, and 
defective tail retraction. On the contrary, myosin IIB deficiency causes 
unstable protrusions, and increases random intrinsic migration. Myosin IIB 
promotes directional migration by forming contractile actomyosin bundles at 
the cell rear, which prevent protrusion formation and thereby promote 
directional migration. A small GTPase, RhoA activates ROCK1, which 
subsequently phosphorylates myosin phosphatase and the regulatory light 
chain on myosin II to increase the actin–myosin contractility and stimulate the 




1.2 Adaptor protein p130Cas 
An adaptor protein, p130Cas (Crk-associated substrate, hereafter referred to as 
Cas) was originally found as a prominent tyrosine-phosphorylated protein in v-
crk (Matsuda et al., 1990) and v-src (Reynolds et al., 1989) transformed cells 
(Janostiak et al., 2014). In fact, Cas is the founding member of Cas family in 
vertebrate. Cas and the other three structurally similar proteins, namely 
Efs/Sin, HEF1/NEDD9 and CasS4, constitute the Cas protein family 
(Tikhmyanova et al., 2010; Janostiak et al., 2014). Cas is the most abundantly 
expressed among the four Cas family members in vivo or in cultured cells. 
Phosphorylation status of Cas is important as it influences the subcellular 
localization of the protein. In biochemical preparations, phosphorylated Cas is 
predominantly detected from the focal adhesions, membranous, nuclear and 
insoluble cytoskeletal fractions; whereas unphosphorylated Cas can be found 
in the cytosolic fraction (O'Neill et al., 2000). Members of the Cas family have 
been recognized as important multi-functional adaptor/scaffold/docking 
proteins modulating cellular signaling and influencing biological processes, 
such as cell cycle, migration, adhesion, wound healing, differentiation and 
survival, in both normal and pathological conditions (Defilippi et al., 2006; 
Singh et al., 2007; Tikhmyanova et al., 2010). 
 
1.2.1 Structural and functional analysis of Cas domains 
The primary structure of Cas indicates that it has a function as a 
docking/scaffolding protein, lacking any enzymatic or transcriptional activity 
but having various domains and motifs for mediating interaction with other 
proteins (Donato et al., 2009). Identification of several conserved domains 
within Cas through functional analysis reveals the sites for post-translational 
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modifications, mainly consisting of serine and tyrosine phosphorylation, and 
protein-protein interactions. Similar to those of other Cas family members, the 
domain structure of Cas is characterized by four main elements (Figure 1.1), 
namely an amino (N)-terminal Src homology 3 (SH3) domain; a large central 
substrate domain (SD); a serine-rich region (SRR) and a carboxyl (C)-terminal 







Figure 1.1 – Schematic diagram of Cas domain structure. Murine adaptor 
protein Cas is 874 amino acids long with a N-terminal Src homology (SH3) 
domain, a substrate domain (SD) located centrally, a serine-rich region (SRR) 
and a C-terminal domain. Notably, Src-binding domain (SBD) can be found 
within the region of C-terminal domain. In addition, the N-terminal region 
contains a proline-rich region (PRR) while 15 YxxP motifs are located within 
the central SD. Red arrowheads indicate the two reported caspase recognition, 











1.2.1.1 Src homology 3 domain of Cas 
Cas contains an N-terminal SH3 domain that shares a high sequence 
homology with other Cas family members. The SH3 domain of Cas binds to 
the polyproline motifs of the tyrosine kinases FAK or PYK2, the tyrosine 
phosphatases PTP1B or PTP-PEST and other proteins such as C3G, vinculin 
or CIZ (Janostiak et al., 2014). FAK is a widely expressed non-receptor 
protein tyrosine kinase predominantly localized to focal adhesions. It appears 
to serve as a convergence point in signaling pathways known to regulate cell 
morphology, locomotion, growth as well as differentiation (Polte and Hanks, 
1996). The interplay between Cas SH3 domain and FAK leads to tyrosine 
phosphorylation of Cas substrate domain (CasSD) by Src that is bound to FAK 
autophosphorylation site, Tyr-397 through its SH2 domain (Polte and Hanks, 
1996). Such interaction results in further modification of FAK by Src, 
including phosphorylation of the catalytic domain Tyr-576 and Tyr-577 which 
in turn elevates FAK kinase activity (Polte and Hanks, 1996). The expression 
of a truncation mutant of Cas that lacks the SH3 domain impairs tyrosine 
phosphorylation and dephosphorylation events of CasSD, since Cas SH3 
domain is crucial for Cas to be localized to focal adhesions where Cas is 
phosphorylated  (Fonseca et al., 2004).  
A novel phosphorylation site tyrosine-12 (CasY12) within Cas SH3 
domain has recently been reported to regulate the focal adhesion assembly, 
cell migration, and invasiveness of Src-transformed cells (Janostiak et al., 
2011). CasY12 has later been identified as a binding site for vinculin 
(Janostiak et al., 2014; Goldmann, 2014), a prominent mechano-coupling 
protein in focal adhesions. Cas-vinculin interaction is required for stretch-
induced phosphorylation of Cas at the tyrosine-410 (CasY410) (Janostiak et 
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al., 2014). It has also been shown that the mobility of individual Cas and 
vinculin molecules within focal adhesions is significantly affected by the Cas-
vinculin interplay (Janostiak et al., 2014).  
 
1.2.1.2 Substrate domain of Cas (CasSD) 
The major sites of Cas tyrosine phosphorylation lie in the substrate domain 
(CasSD) located in the central region of Cas. CasSD is characterized by the 
existence of fifteen YxxP motifs; at least ten of these scattered motifs can be 
efficiently phosphorylated by Src (Meederink et al., 2010).  
Although a tyrosine phosphorylation activity of FAK on Cas has not 
been established to date, FAK can interact with the SH2 domain of Src to 
recruit and activate Src, which in turn phosphorylates Cas at CasSD. 
Furthermore, the direct binding of the Src SH3 domain to the proline-rich 
region in Src-binding domain (SBD) of Cas will trigger Src activation to 
phosphorylate CasSD (Meederink et al., 2010). Upon tyrosine 
phosphorylation by Src, CasSD creates the binding sites for effector proteins 
with SH2 or phosphotyrosine-binding (PTB) domains, which consequently 
further activate series of downstream signaling cascades. Of those are the ones 
that involve the SH2/SH3 adaptors, Crk and Nck, which can be activated to 
promote protrusions of the plasma membrane (Meederink et al., 2010).  
CasSD tyrosine phosphorylation, which takes place preferentially 
within focal adhesions, is further enhanced by cellular stretching (Sawada et 
al., 2006). Cas was first recognized as a potential force sensor by Sawada and 
colleagues, who managed to show that the CasSD is phosphorylated upon 
mechanical stretching both in intact cells and in vitro (Sawada et al., 2006). 
Therefore, signaling mediated by CasSD tyrosine phosphorylation can be 
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further implicated in the process of mechanotransduction (Donato et al., 2009). 
In non-stretched or relaxed conditions, CasSD forms compact and folded 
conformations by which the accessibility of tyrosine residues to 
phosphorylation is hindered. Upon mechanical stretching, the CasSD extends 
while exposing cryptic tyrosine residues that are subsequently phosphorylated 
by Src-family kinases (Sawada et al., 2006). The stretch-induced 
phosphorylation of CasSD induces the binding of signaling molecules such as 
the Crk/C3G complex and subsequently leads to the activation of Rap1 
GTPase, ERK and other signaling pathways (Sawada et al., 2006; Janostiak et 
al., 2014). CasSD tyrosine phosphorylation is greatly enhanced after tyrosine 
phosphatase inhibition (Janoštiak et al., 2014; Stover et al., 1991).Cas 
molecules with phosphorylated CasSD has been observed localized 
predominantly to the focal adhesions and the nascent integrin contact site at 
the cell periphery. The phosphorylation-defective Cas mutant, Cas15YF, 
which has all the 15 YxxP motifs substituted with FxxPs (Figure 1.2), still 
localizes to the focal adhesions when expressed in adherent cells. These 
observations indicate that CasSD tyrosine phosphorylation is not essential for 








Figure 1.2 – Schematic depictions of wild-type Cas and its 
phosphorylation-defective mutant, Cas15YF.  (A) Full-length wild-type Cas 
indicating the N-terminal Src homology 3 (SH3) domain, centrally located 
substrate domain (SD) with 15 scattered YxxP motifs featured, Src-binding 
domain (SBD) with proline-rich motif RPLPSPP highlighted, and a Cas-
family C-terminal homology domain (CCHD). (B) Full-length Cas15YF 
depiction with all 15 tyrosine (Y) residues substituted with phenylalanine (F) 






1.2.1.3 Serine-rich region of Cas 
Compared to other functional domains of Cas, less is known as to the function 
of the serine-rich region (SRR) of Cas. Located in the C-terminal side of 
CasSD, SRR has relatively low sequence homology among the Cas family 
members, with the exception of numerous serine residues. Nuclear magnetic 
resonance (NMR) spectroscopy revealed that SRR is a stable domain with a 
four-helix bundle, functioning as a protein interaction motif.  Strong structural 
similarity to four-helix bundles was found in other focal adhesion components 
such as FAK, α-catenin, or vinculin (Briknarová et al., 2005). Putative 
phosphorylation and interaction sites with the 14-3-3 family regulators are 
present in Cas SRR (Briknarová et al., 2005).  
 
1.2.1.4 Carboxyl-terminal domain of Cas 
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Within the C-terminal domain of Cas, sequence analysis reveals a Src-binding 
domain (SBD) and a conserved Cas-family C-terminal homology (CCH) 
domain, also known as FAT-like domain. The SBD is a bipartite binding site 
consisting of a YDYVHL motif and a proline-rich region (RPLPSPP) that 
serve as consensus binding sites for SH2 and SH3 domains of Src kinases, 
respectively (Tikhmyanova et al., 2010; Nakamoto et al., 1996). PI-3 kinase 
and the adaptor protein p140 Cas-associated protein (p140Cap), both of which 
contain SH3 domains, have also been reported to form complexes with Cas 
through the binding to the C-terminal proline-rich region of Cas (Di Stefano et 
al., 2011). AND-34/BCAR3, one of the three NSP family members, has been 
reported to bind to Cas CCH domain, adjacent to the bipartite SBD. Such 
interaction induces anti-estrogen resistance in breast cancer cell lines 
(Makkinjeet al., 2012). However, only a subset of the signaling properties of 
BCAR3, which specifically amplifies motility, is dependent upon the complex 
formation with Cas (Makkinje et al., 2012).Similar to the disruption of SH3 
domain of Cas, deletion of Cas CCH domain alone is sufficient to impair focal 
adhesion targeting (Donato et al., 2010). Therefore, it is proposed that the Cas 
CCH domain can also serve as focal adhesion-targeting domain, akin to the 
FAK FAT domain.  
 
1.3 Tensin 1 
Originally identified in the mid-1980s as an actin-binding contaminant from a 
vinculin preparation (Wilkins et al., 1986; Wilkins and Lin, 1986), tensin 1 is 
a cytoskeletal phosphoprotein that links β integrin cytoplasmic tails to the 
actin cytoskeleton at the cell-matrix adhesion sites (McCleverty et al., 2007). 
Initial characterization of the chicken tensin 1 protein using SDS-PAGE, 
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dynamic light scattering, and gel filtration, suggested that tensin 1 is a large 
molecule (~200 kDa) that can form a dimer (Lo et al., 1994).  Chicken tensin 
1 consists of 1744 amino acid residues (Lo et al., 1994). Besides that, chicken 
tensin 1 is known to contain three actin-binding sites; two at its N-terminus 
which can bind to the sides of actin filaments, and one in the central region of 
the molecule that is thought to cap actin filament barbed ends (Lo et al., 1994). 
It was named tensin for its putative role in anchoring actin filaments to the 
focal adhesions and maintaining tension generated in the cell simultaneously 
(Lo et al., 1994).   
 Tensin 1 is rapidly recruited to the assembling focal adhesions upon 
integrin ligation (Lo, 2004). In addition to focal adhesions, tensin 1 is also 
localized to adherens junctions in vivo, including the zonula adherens, 
intercalated discs and myotendinous/neuromuscular junctions (Lo et al., 1994). 
Tyrosine phosphorylation of tensin 1 is triggered by the ECM attachment, 
treatment with platelet-derived growth factor (PDGF), thrombin or angiotensin, 
and upon transformation by oncogenes such as v-Src and Bcr/Abl (breakpoint 
cluster region/abelson) (Chen et al., 2002). Tensin 1 is reportedly cleaved by 
calpain II, a well-recognized focal adhesion protease involved in the assembly 
and disassembly of focal adhesions (Chen et al., 2002). Taken together, these 
findings suggest that tensin 1 serves as a bridge connecting ECM, the actin 
cytoskeleton, and signal transduction (Chen et al., 2002).  
 Tensin 1 knockout mice develop normally for several months, although 
it is broadly expressed during mouse embryogenesis as well as in several adult 
tissues (Chen et al., 2002). However, they show signs of weakness with 
growth due to progressive multiple large cyst formation in the kidney, and 
eventually died from renal failure (Chen et al., 2002). All in all, these 
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observations indicate that tensin 1 is dispensable for mouse embryogenesis but 
is required for the maintenance of normal renal functions.   
 
1.3.1 Functional and structural domains homology of tensin family 
The four members of the human tensin family display high sequence 
homology with various domains of several well-characterized structural 
proteins (Figure 1.3). Tensins 1, 2 and 3 are large (molecular weight ~150-
200 kDa) multi-domain proteins whereas cten (also known as tensin 4) is a 
shortened protein, which is approximately half the length (molecular weight 
~77 kDa) of the larger tensins. Significant homology at the C-termini is 
displayed for all four tensins, which contains a SH2 domain and a PTB 
domain (Lo et al., 1994; Lo et al., 1994).  
SH2 domains are present in a wide variety of proteins involved in 
signal transduction (Lo et al., 1994).  Typical SH2 domain consists of 
approximately 100 amino acid residues and specifically binds to 
phosphotyrosine-containing peptide (Wavreille and Pei, 2007). The tensin 1 
SH2 domain has been shown to bind to numerous phosphotyrosine proteins, 
two of which have been identified as phosphoinositide 3-kinase (PI3-kinase) 
and Cas (Wavreille and Pei, 2007).  In particular, the SH2 domain of tensin 1 
shares homology with an amino acid sequence in Bcr, a component of chronic 
myeloid leukemia-associated proteins.  Bcr binds to the SH2 domain of the 
non-receptor tyrosine kinase Abl, depending on Bcr phosphorylation on 
serine/threonine but not tyrosine. It is therefore possible for tensin 1 to provide 
binding sites for the SH2 domain of Abl, which can also be localized at focal 
adhesions (Lo et al., 1994). The PTB domain of tensin 1 shows high affinity to 
the specific regions in β-integrins that consist of hydrophobic residues 
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followed by an NPxY motif (McCleverty et al., 2007). Tensin 1 associates 
primarily with ECM-bound α5β1 integrin in focal adhesions containing αVβ3 
integrin (McCleverty et al., 2007). The NPxY motif typically adopts a reverse 
β-turn that is crucial for binding to PTB domains.  
The three larger tensin isoforms (tensin 1, 2, 3) display homology at 
their N-termini, where two actin-binding domains can be found. Focal 
adhesion-binding (FAB) sites, which are essential for its subcellular 
localization, are located at the N- and C-terminal regions of chicken tensin 
1(Chen and Lo, 2003). These FAB sites are presumed to be conserved in the 
human tensin family proteins. Human tensin 1 contains a centrally-located 









Figure 1.3 – Functional and structural domains of tensins. (A) Schematic 
diagram representing chicken tensin 1 in which the protein is divided into 
three regions that are each involved in mediating protein-protein interactions. 
The N-terminus of tensin 1 contains actin-binding domain (ABD) Ia and Ib 
which associates with actin filaments. This region represents a focal adhesion-
binding (FAB) activity at the N-terminus. The central region of tensin 
1contains ABD II that binds to the barbed end of actin filaments. The C-
terminus contains a SH2 domain, PTB domain, and another FAB site. The 
SH2 domain binds to PI3-kinase, FAK and Cas. The PTB domain interacts 
with NPxY motifs of integrin β tails. The amino acid numbers are given based 
on the chicken tensin 1 sequence. (B) Schematic diagrams representing human 
tensin isoforms. Human tensin 1, tensin 2, tensin 3, and cten are highly 
conserved at both N- and C-terminal regions. A C1 domain, which denotes 
protein kinase C conserved region 1, is only found in tensin 2.  (Diagram 











































For cells to migrate on the extracellular matrix, they need to generate forces 
and transmit them to the cell-matrix contact sites.  While the continuous 
inward movement of actin filaments transduces myosin-originated traction 
forces, a clutch-like transmission mechanism is required to reconcile the 
discrepancy between the motile and stationary parts in the cytoskeleton-
adhesion linkage.  
 We have previously reported that Casis involved in such a clutch 
mechanism as it supports cell migration by linking the actomyosin-driven 
actin retrograde flux to the cell-ECM adhesions (Machiyama et al., 2014).  We 
have shown that both the Src-mediated tethering and the actomyosin-driven 
displacement of Cas are crucial for rapid cell migration. Although we have 
demonstrated that Cas molecules are dissociated from focal adhesions upon 
CasSD phosphorylation, it remains elusive how actin cytoskeletons are linked 
to Cas molecules with phosphorylated CasSD.  
 In search for a molecule that can bind to both actin filaments and 
phosphorylated Cas simultaneously, we consolidated previous reports on 
actin-associating proteins that may bind to phosphotyrosine-containing 
polypeptides. Tensin 1 is a focal adhesion protein that has been reported to 
associate with actin filaments through its actin-binding domains located in the 
N-terminal and central regions of the molecule. In addition, tensin 1 has 
phosphotyrosine-binding SH2 and PTB domains, and it has been documented 
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to bind to or co-immunoprecipitate with Cas in vitro. Therefore, tensin 1 
appears to meet the requirement for the molecule that links actin and Cas. 
The objective of this study is to test our hypothesis that tensin 1 
constitutes a component of the above-mentioned clutch mechanism by linking 
inwardly moving actin filaments to phosphorylated Cas molecules at focal 




















Figure 2.1 – Temporal association of tensin 1 and Cas at focal adhesions 
links inwardly moving actin cytoskeletons to cell migration. Diffuse 
unphosphorylated Cas molecules in the cytosol are recruited to focal adhesion 
complexes during cell migration. Src tethers Cas to focal adhesions and 
phosphorylation of Cas substrate domain (CasSD) ensues. Molecular complex 
forms when tensin 1 binds to phosphorylated Cas through the SH2 and PTB 
domains. Continuous actin inward flux exerts pulling forces to the molecular 
complexes including Cas, displacing them from the adhesion sites, thus 
driving cell migration. (Schematic diagram adapted and modified with 








































3 MATERIALS AND METHODS 
3.1 Cell culture 
 Mouse embryonic fibroblasts (MEFs), human embryonic kidney 
(HEK) 293T cells, and 293A cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM; [Nissui Pharmaceutical Co., Tokyo, Japan], 
containing 2.0 mM L-glutamine, 10% heat-inactivated fetal bovine serum 
[FBS], 0.2% sodium bicarbonate [NaHCO3] solution, 100 units/mL penicillin 
and 100 μg/mL streptomycin). All cell culture reagents were bought from 
Gibco® (Thermo Fisher Scientific Inc., Waltham, MA) unless otherwise 
mentioned. Besides that, all cell lines were maintained in a CO2 incubator 
(Thermo Fisher Scientific Inc.) under standard cell culture environment at 
37oC supplied with 5% CO2. All stably expressing MEFs cell lines were also 
cultured under the same abovementioned cell culture condition. These cells 
lines include CasKO cells, GFP only-expressing cells, GFP-CasWT-
expressing cells, GFP-Cas15YF-expressing cells, PA-GFP-Cas and PA-
mCherry-actin-expressing cells, GFP-CasWT and paxillin-mCherry-
expressing cells, and tensin 1-silenced cells. 
3.2 Transfection 
 Transfection of plasmids was performed using GeneJuice® 
Transfection Reagent (Merck KGaA, Darmstadt, Germany) according to the 
user’s manual. One day prior transfection procedure, cells were plated in a cell 
culture dish at about 70% confluency. For each transfection, transfection 
reagent and plasmids were diluted in Opti-MEM® I reduced serum medium 
(Gibco®, Thermo Fisher Scientific Inc.) and incubated at room temperature 
for 15 min to allow formation of transfection complexes before adding drop 
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wise onto the cells. After incubating at 37oC for approximately 16 hours, the 
culture medium was replaced with fresh medium. 
3.3 Retroviral infection 
All stable cell lines established and used in this research work were 
generated using a retrovirus vector system. Retroviral infection was conducted 
according to Kawauchi et al., 2008 and Kawauchi et al., 2012. Retrovirus was 
generated by co-transfecting retroviral expression plasmid (pBabe-hygromycin 
or pSuper-hygromycin constructs) and an ecotropic helper plasmid that 
encodes viral envelope protein into HEK 293T cells. Transfection was done as 
the aforementioned transfection method. Twenty hours post transfection, the 
cell culture medium was exchanged with fresh culture medium and then 
further incubated for another 24 hours at 37oC. Subsequently, the virus-
containing medium was collected 24 hours post transfection, filtered through a 
0.45 mm filter (Millipore, Billerica, MA) and used immediately for infection.  
 Polybrene in a final concentration of 8 µg/mL was then slowly added 
into the filtered virus-containing medium, mixed thoroughly by gentle 
pipetting and then added to target cell line which was seeded at low 
confluency in a 6-well plate (Nunc™, Thermo Fisher Scientific™ Waltham, 
MA) one day prior retroviral infection. The opening of 6-well plate was then 
sealed with tape and spun in a swing-out centrifuge at 6000 rpm at 37oC for 1 
hour. Lastly, the plate was then cultured in CO2 incubator after removing the 
tape carefully.  
 After 24 hours post infection, the virus-containing medium in the 6-
well plate was replaced with fresh medium and allowed to continue growing 
till near confluency before transferring to a 10 cm cell culture dish (Nunc™) 
29 
 
for appropriate antibiotic selection. Successful infected cell populations were 
selected in hygromycin with final concentration 300 µg/ml for 3 days. After 
antibiotic selection, cells were screened by either western blotting or 
quantitative real-time polymerase chain reaction (qPCR) to examine the 
expression efficiency of shRNA or target gene. Stable cell lines established via 
retroviral infection were evaluated either by immunoblot assays or polymerase 
chain reaction (PCR) to determine the knockdown efficiency or expression of 
the target genes.  
3.4 Antibodies and chemical reagents 
 Anti-phospho-Cas (Y165) polyclonal (Cell Signaling Technology, Inc., 
Danvers, MA), anti-Cas polyclonal (αCas3) (Sakai et al., 1994; Wilkins et al., 
1986; Kawauchi et al., 2012; Machiyama et al., 2014), anti-β -actin 
monoclonal (Sigma-Aldrich®, St. Louis, MO), anti-Src (clone GD11; 
Millipore), anti-FLAG® M2 monoclonal (Sigma-Aldrich®), anti-GFP 
monoclonal (JL-8; Clontech Laboratories, Inc., Mountain View, CA) 
antibodies were used for immunoblot, co-immunoprecipitation (Co-IP) and 
immunofluorescence analyses. 
For immunoblot analyses, horse radish peroxidase (HRP)-conjugated 
antibodies against mouse or rabbit IgG were purchased from Amersham (GE 
Healthcare Life Sciences, Piscataway, NJ). Alexa Fluor® 546-conjugated goat 
anti-rabbit IgG (Molecular Probes, Thermo Fisher Scientific, Carlsbad, CA) 
was used as secondary antibodies in immunofluorescence analyses. 
Phenylarsine oxide (PAO) was purchased from Sigma-Aldrich® and 
was prepared in 330 mM stock concentration in DMSO.  
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3.5 Adenoviral transduction 
 The recombinant adenovirus expressing GFP-tensin 1-SH2PTB was 
generated using the ViraPower™ Adenoviral Expression System 
(Invitrogen™, Thermo Fisher Scientific, Inc.). GFP only recombinant 
adenovirus was a gift from Dr. Keigo Araki (Araki et al., 2013). Tensin 1’s 
SH2PTB domain was first cloned into GFP-included pCR 8/GW/TOPO vector 
(this vector was provided by Dr. Keigo Araki). LR recombination reaction was 
then set up to transfer GFP-tensin 1-SH2PTB construct into Gateway® 
destination vector,  pAd/CMV/V5-DEST™ (Invitrogen™, Thermo Fisher 
Scientific, Inc.). pAd-GFP-tensin 1-SH2PTB was then digested with PacI 
enzyme (New England Biolabs, Inc, Ipswich, MA) and gel purified using 
QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). After gel purification, 
the digested pAd-GFP-tensin 1-SH2PTB fragment was dissolved in TE buffer 
and was used to transfect HEK 293A cells.  
 One day prior transfection, HEK 293A cells were plated into two 6 cm 
dishes (Nunc™) at approximately 70% confluency. Transfection was 
performed using Lipofectamine® 2000 (Invitrogen™, Thermo Fisher 
Scientific, Inc.) with 1 µg of pAd-GFP-tensin 1-SH2PTB. Adenovirus-
containing medium from the 2 dishes were then collected as crude adenoviral 
stock after 3 days of incubation. This crude adenoviral stock was then spun 
down, both supernatant and cells pellet were kept. Cells pellet was then 
subjected to three cycles of freezing at -80oC and thawing at 37oC before a 
final centrifugation to get the supernatant. Second generation of adenoviral 
supernatant was obtained by adenovirus infection into HEK 293A cells using 
the cleared adenovirus supernatant and incubated for 3 days. Three cycles of 
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freezing and thawing procedures ensued to obtain the cleared adenovirus-
containing supernatant. Lastly, this second generation adenovirus was used to 
infect HEK 293A cells in three 15 cm dishes in order to get the third 
generation of adenovirus supernatant. After performing three cycles of freeze 
and thaw procedures, the third generation recombinant adenovirus was then 
purified with AdEasy Virus Purification Kits (Agilent Technologies, Palo 
Alto, CA) according to manual.  
The purified GFP-tensin 1-SH2PTB adenovirus was then used to 
transduce the target cell lines, which were CasKO MEFs and CasKO MEF 
stably expressing mCherryCas. These cells were transduced either GFP only 
or GFP-tensin 1-SH2PTB expressing adenoviruses at a multiplicity of 
infection (MOI) of 50 plaque-forming unit (pfu) for 4 days.  
3.6 Preparation of cell lysates 
 For immunoblot analyses involving protein expression checking, cells 
were solubilized with 2 X sodium dodecyl sulphate (SDS) sample loading 
buffer (12% [w/v] SDS, 30% [v/v] glycerol, 600 mM β-mercaptoethanol 
[βME], and 0.1% [w/v] bromophenol blue in 150 mM Tris-HCl pH 6.8) 
immediately after removal of cell culture medium.  
 Cell lysates for co-IP assay were prepared by solubilizing the cells 
with ice cold golden lysis buffer with slight modification (20 mM Tris [pH 
7.9], 137 mM NaCl, 10% glycerol, 1% Triton™ X100, 5 mM EDTA, 1 mM 
EGTA, 1 mM Na3VO4, 10 mM NaF, 1 mM sodium pyrophosphate, 0.5 mM β-
glyceroposphate, 1 mM dithiothreitol [DTT] and protease inhibitor cocktail 
[Roche Molecular Biochemicals, Indianapolis, IN]) (Donato et al., 2010). All 
chemicals were purchased from Sigma-Aldrich® unless otherwise stated. The 
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cell lysates were then transferred into individual 1.5 mL microfuge tubes 
(Axygen, Union City, California), shearing with 27G blunt end needles 
followed by incubation on ice for 30 minutes. The lysed samples were then 
centrifuged at 20,000 x g for 40 minutes and clarified supernatants were 
collected in fresh pre-chilled 1.5 mL microfuge tubes for co-IP assay. All 
procedures were executed either on ice or at 4oC unless otherwise stated. 
3.7 Western blotting 
3.7.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 SDS-PAGE was carried out using either Invitrogen® NuPAGE® SDS-
PAGE gel system or Bio-Rad Mini-PROTEAN® Tetra cell (Bio-Rad 
Laboratories, Inc., Hercules, CA). All gel electrophoresis procedures were 
performed according to manufacturer’s manual. Extracted protein lysates were 
added with 2 X SDS samples loading buffer and mixed thoroughly. Samples 
were then denatured at 95oC for 5 minutes on a heat block, followed by 
centrifugation at maximum speed at room temperature for 1 minute to pellet 
down any residues prior to loading into the gels. The protein samples were 
resolved by SDS-PAGE along with Precision Plus Protein™ All Blue 
standards (Bio-Rad Laboratories, Inc.).  
For western blot experiments using NuPAGE® SDS-PAGE gel 
system, precast polyacrylamide gels (NuPAGE® Novex® Bis-Tris gels) were 
used and gel electrophoresis was performed in MOPS [3-(N-Morpholino) 
propanesulfonic acid]-SDS buffer (50 mM MOPS, 50 mM Tris-Base, 0.1% 
SDS, 1 mM EDTA, pH 7.7). For Mini-PROTEAN® Tetra cell, 10% 
acrylamide/bis SDS-PAGE gel was casted as shown in table 3.1 and gel 
electrophoresis was conducted in Tris-Glycine-SDS buffer (25 mM Tris-base, 
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192 mM Glycine, 0.1% [w/v] SDS). After running electrophoresis, the 
resolved gels were either stained with Commassie Brilliant Blue (CBB) 
staining solution or transferred onto nitrocellulose membranes. Acrylamide/bis 
solution (30% stock; 29:1 ratio [3.3% C]), ammonium persulfate (APS), N, N, 
N', N'-tetramethylethylenediamine (TEMED) and SDS powder were 
purchased from Bio-Rad Laboratories, Inc. whereas; Tris-base and glycine 








Table 3.1:Recipe for preparation of SDS-PAGE gels. Measurement units 
are all in milliliter (mL) unless otherwise stated. 
Reagents 
Resolving gel per 10 mL Stacking gel per 4 mL 
10% 4% 
30% Acrylamide/Bis 3.3 0.53 
1.5 M Tris-HCl, pH 8.8 2.5 - 
1.0 M Tris-HCl, pH 6.8 - 0.5 
MilliQ Water 4.0 2.9 
10 % (v/v) SDS 0.1 0.04 
10 % (v/v) APS 0.1 0.04 




3.7.2 Immunoblot assay 
 Extracted protein lysates were mixed thoroughly with 2 X SDS sample 
loading buffer and resolved on SDS-PAGE gels as described in the earlier 
section 3.7.1. The proteins in the gels were then transfered onto Protran™ 
nitrocellulose (NC) membranes (0.2 µm; Whatman™, GE Healthcare, Little 
Chalfont, Buckinghamshire, UK). The transferred membranes were incubated 
in a blocking buffer (1X tris-buffered saline with Tween, TBST containing 5% 
skimmed milk [Bio-Rad Laboratories, Inc.]) for 1 hour on a shaker at room 
temperature (TBST; 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween® 
20). They were then rinsed briefly with 1X TBST thrice, followed by 
overnight incubation with primary antibodies diluted in 1X TBST, containing 
5% bovine serum albumin (BSA). The membranes were then incubated with 
secondary HRP-conjugated antibodies, pre-diluted with 1X TBST containing 
3.5% skimmed milk (Bio-Rad Laboratories, Inc.) for 1 hour after several 
washing off the primary antibodies with 1X TBST. Protein of interests were 
visualized with SuperSignal West Pico Chemiluminiscent Substrate (Thermo 
Fisher Scientific) and Fuji SuperRX X-ray films (FUJIFILM Medical 
Systems, Fuji, Japan), which were developed using a Kodak X-ray film 
processor. Overnight primary antibody incubation was performed with on a 
bench-top shaker in a cold room at 4oC.  
3.8 Coomassie Brilliant Blue staining of SDS-PAGE gels 
After SDS-PAGE procedures previously mentioned in section 3.7.1, 
the polyacrylamide gels were stained in Coomassie Brilliant Blue (CBB) 
staining solution (0.25% [w/v] Coomassie Blue R-250 in 50% [v/v] methanol 
and 10% [w/v] glacial acetic acid). Continuous shaking at room temperature 
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for 20 min on a bench-top shaker ensued. The staining solution was then 
exchanged with destaining buffer (30% [v/v] methanol, 10% [w/v] glacial 
acetic acid) to remove excess background. Several replenishments of 
destaining buffer were required until background of the gel was destained. 
3.9 Plasmid construction 
3.9.1 Primers and oligonucleotides 
All primers and oligonucleotides were designed independently with the 
necessary restriction enzyme sites incorporated. Their specificities against the 
gene of interest were also checked using BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) before ordering from AIT biotech 
(Singapore) or Sigma-Aldrich ®. 
3.9.2 Construction of pSuper sh-tensin 1 
Tensin 1 silencing short hairpin RNA (shRNA) was constructed by 
first designing the target sequences of murine tensin 1 using RNAi Design 
Tool provided by Oligoengine (Seattle, WA). After screening for suitable 
design, the oligonucleotides were generated with 5’ overhangs and a central 
hairpin loop sequence according to the pSuper RNAi System™ (Oligoengine) 
manual. The complementary pairs of shRNA oligonucleotides containing 
mouse tensin 1-shRNA (5′-GCCTTTGTTTCTGCATCATGT-3′), was then 
annealed and ligated into pSuper-retro-hygromycin vector (Guo et al., 2014; 
Yamauchi et al., 2014) linearized with BamHI and HindIII restriction enzymes 
(FastDigest restriction enzymes, Thermo Fisher Scientific, Inc.). 
Subsequently, the ligated construct was transformed into competent cells, 
DH5α and screened for positive constructs. Plasmid amplification and 
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collection was performed using QIAprep Spin Miniprep Kit (Qiagen) and sent 
for DNA sequencing for sequence confirmation. 
3.9.3 Construction of pBabe mCherry-Cas 
To generate pBabe mCherry-Cas construct, pBabe vector containing 
hygromycin selection gene was linearized by BamHI and EcoRI restriction 
enzymes (FastDigest enzymes). Full length Cas with mCherry-tagged at N-
terminal was amplified by PCR with primers containing either BamHI or 
EcoRI at forward and reverse primer respectively. The PCR condition was set 
at 98oC for 5 minutes, followed by 30 cycles of 98oC 10 seconds, 55oC 5 
seconds, and 72oC for 5 minutes. PCR reaction mixture consisted of 25 µL 2X 
PrimeSTAR GC Rich buffer containing Mg2+ (Takara Bio Inc., Shiga, Japan), 
4 µL 2.5 mM dNTP mixture, 1 µL 10 mM forward primer, 1 µL 10 mM 
reverse primer, 100 ng DNA template, 0.5 µL PrimeSTAR HS DNA 
polymerase (Takara), and then topped up to 50 µL with sterile nuclease-free 
MilliQ water (MQ water; Millipore).  The PCR product was then purified by 
QIAquick Gel Extraction Kit (Qiagen) and double-digested with BamHI and 
EcoRI restriction enzymes. The PCR product was then purified again by DNA 
gel extraction and ligated into the linearized pBabe hygromycin vector to 
generate pBabe retrovirus expression construct. After ligation, the ligation 
products were transformed into competent cells, DH5α and screened for 
positive clones. Plasmids were then purified using QIAprep Spin Miniprep Kit 
(Qiagen) and sent for DNA sequencing.  
3.9.4 Construction of pCAGGS Cerulean-tensin 1 variants 
 GFP-tensin 1 construct was a gift from Dr. S. H. Lo (Lo, 2004; Di 
Stefano et al., 2011). To generate pCAGGS Cerulean-tensin 1 variants, 
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Cerulean fragment was first amplified using PCR with primers flanking the 
gene with EcoRI and ClaI restriction enzyme sites and sub-cloned into 
pCAGGS vector. Similarly, tensin 1 variants (full length tensin 1, tensin 1-
SH2PTB, tensin 1-ΔSH2PTB) were then sub-cloned into pCAGGS-Cerulean 
vector using primers with ClaI and NotI restriction enzymes sites.  PCR 
condition was set at 98oC for 5 minutes, followed by 30 cycles of 98oC 10 
seconds, 55oC 5 seconds, and 72oC for 1 minute. PCR reaction mixture 
consisted of 10 µL 5X PrimeSTAR buffer containing Mg2+ (Takara Bio Inc., 
Shiga, Japan), 4 µL 2.5 mM dNTP mixture, 1 µL 10 mM forward primer, 1 µL 
10 mM reverse primer, 100 ng DNA template, 0.5 µL PrimeSTAR HS DNA 
polymerase (Takara), and then topped up to 50 µL with sterile nuclease-free 
MilliQ water (MQ water; Millipore).  
3.9.5 Annealing of oligonucleotides 
To generate shRNA, annealing of oligonucleotides was carried out. 
Annealing reaction mixture (1 µL forward oligonucleotide, 1 µL reverse 
oligonucleotide and 8 µL sterile MQ water) was incubated at 95oC for 2 
minutes and then allowed to cool gradually to room temperature over a period 
of 2 hours to allow the complementary pair of oligonucleotides to anneal. 
3.9.6 Restriction enzyme digestion 
All restriction enzyme digestion was done using FastDigest enzymes 
unless otherwise stated. Intact plasmids or PCR amplified products was 
incubated with the appropriate restriction enzymes in a 20 to 25 µL reaction 
volume (1X universal FastDigest Green buffer) at 37oC for 15 to 30 minutes 
according to manufacturer’s instruction. After incubation, the digestion 
reaction mixture was loaded into agarose gel for gel electrophoresis. The 
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correct band from each well on the gel was extracted and performed DNA gel 
extraction to obtain the purified digested product.  
3.9.7 Agarose gel electrophoresis 
All agarose gel electrophoresis procedures were performed using 
Mupid®-2plus electrophoresis system (Advance co. ltd, Chuo-ku, Tokyo). 
Samples from restriction enzyme digestion and PCR products were mixed 
with 10 X loading buffer before resolving in 1% agarose gel (1 g agarose 
powder [Sigma-Aldrich] in 100 mL 1 X TAE buffer [40 mM Tris-acetate pH 
8.0, 1 mM EDTA]) containing SYBR® Safe DNA gel stain (50,000X dilution; 
Invitrogen®). Agarose gel electrophoresis was run at 100 V for 20 minutes at 
room temperature and visualization of the DNA was performed using the 
Molecular Imager Gel Doc XR system (Bio-Rad). GeneRuler 1kb DNA ladder 
(Thermo Fisher Scientific, Inc.) was run alongside as a marker for DNA size 
reference. 
3.9.8 DNA gel extraction 
All DNA gel extraction steps involved in this research were done using 
QIAquick Gel Extraction Kit (Qiagen) according to protocol provided. DNA 
samples from agarose gel were excised using a sterile blade. The weight of the 
gel was determined and treated with buffers provided in the kit according to 
protocol provided. The eluted DNA samples were collected in a 1.5 mL 
microfuge by centrifugation at 14800 rpm on a bench top centrifuge. The 
eluted DNA products were used immediately for subsequent ligation step or 




Mighty Mix DNA ligation kit (Takara) was used for ligation of target 
insert sequence (PCR products or annealed products) into linearized target 
vector. Ligation was performed to generate intact target gene expression 
constructs. Ligation was conducted by mixing equal volume of 2 X Ligation 
mix (Takara) to that of annealed product-vector mixture (4:1 [v/v]) in a 1.5 
mL microfuge tube. One hour of incubation at 16oC water bath ensued. 
Subsequently, the ligation mixture was used for transformation into competent 
cells, DH5α using the heat shock method described later in section 3.10. 
3.9.10 Plasmid purification 
 Colonies observed after transformation and spreading on Luria-Bertani 
(LB) agar plates were picked up using a sterile tip. Single colonies were 
inoculated into individual round bottom tube (Nunc™) with 3 mL of LB broth 
containing the appropriate antibiotics and were subjected to continuous 
shaking overnight at 37oC. Plasmid extraction and purification was performed 
using QIAprep Spin Miniprep Kit (Qiagen) according to the manufacturer’s 
instructions. The quantity and quality of the purified plasmids were checked 
using NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific).  
3.10 Transformation 
Competent cells used for transformation were Escherichia coli (E.coli), 
strain DH5α and BL21. Strain DH5α was used for plasmids amplification 
while strain BL21 was used for expression of recombinant proteins. Intact 
plasmids were mixed gently with 100 µL of competent cells in a 1.5 mL 
microfuge tube and incubated on ice for 15 minutes. Subsequently, the 
mixture was then subjected to heat-shock treatment at 42oC for 1 minute. 
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Immediately after 1 minute of heat-shock, the microfuge tube was returned 
back on ice for another 5 minutes. Afterwards, 900 µL of LB broth was added 
to the mixture, mixed gently. The diluted mixture was then incubated at 37oC 
with shaking at 250 rpm for 1 hour to allow recovery of the cells. The bacteria 
was concentrated to 80 µL volume of LB broth by centrifugation at low speed 
and then spread onto a LB agar plate containing the appropriate antibiotics for 
selection of positive clones. The plates were placed in a 37oC incubator 
overnight for bacteria growth. Colonies were then picked up for inoculation 
the next day. Working concentrations for both ampicillin and kanamycin used 
were 100 µg/mL and 30 µg/mL respectively. 
3.11 Bacterial expression of recombinant protein 
Transformation of pET41-tensin 1-SH2PTB into competent cells strain 
BL21 was performed according to procedures previously mentioned at section 
3.10. Colonies picked up were then inoculated into LB broth containing 
kanamycin with a final concentrationat 30µg/mL. Incubation of inoculated 
bacterial culture at 37oC with shaking at 250 rpm was done until absorbance 
value at optical density (OD) 600 nm, (OD600nm) reached 0.6. Next, the 
bacteria culture was then induced with Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at a final concentration of 0.3 mM. The bacteria culture was then 
incubated for additional 4 hours at 37oC with shaking at 250 rpm.  
To collect the bacterial cells, the culture was spun down to at 8000 rpm 
for 10 minutes at 4oC. Expression of recombinant proteins of GST only and 
GST-tensin 1-SH2PTB were first confirmed by solubilizing the pellet cells 
using 2 X SDS sample loading buffer, mixed thoroughly, and lastly, denatured 
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on a heat block at 95oC for 5 minutes. CBB was then performed as previously 
mentioned at section 3.8.  
After confirming the correct expression of GST-fusion proteins, large 
scale inoculation of bacteria culture was done. Same aforementioned 
procedure was carried out to collect the pellet. The pellet was then 
resuspended in ice cold lysis buffer (5 mM EDTA, 1 mM DTT and protease 
inhibitors in PBS). After that, the bacterial suspension was sonicated in short 
2-seconds bursts alternated with 2-seconds resting on ice. The whole 
sonication was repeated thrice. One percent final concentration of Triton™ 
X100 was then mixed with the sonicated bacterial suspension and the tubes 
were subjected to end-to-end rocking at 4oC for 30 minutes. The mixture was 
then cleared by centrifugation at 15000 rpm for 20 minutes at 4oC twice. The 
supernatant was then kept on ice for subsequent GST pull-down assay.  
3.12 GST pull-down assay 
 GST-fusion proteins were expressed in bacteria as described in 
previous section 3.11. Glutathione agarose (Thermo Fisher Scientific, Inc.) 
slurry was suspended with 0.1% Nonidet P40 (NP40) in PBS buffer and 
removed the buffer. Supernatant of lysed bacterial culture was then added 
accordingly to the glutathione agarose and subjected to rocking at 4oC for 30 
minutes before centrifugation at 2000 rpm for 5 minutes. The agarose was 
then washed thrice with ice cold wash buffer (0.1% NP40 in PBS). All steps 
were carried out on ice or at 4oC cold room unless otherwise stated. 
 FLAG-tagged wild-type Cas (FLAG-CasWT) was transfected into 
HEK 293T cells according to transfection protocol mentioned in section 3.2. 
Before solubilization, the cells were treated with either dimethyl sulfoxide 
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(DMSO) or 20 µM PAO for 10 minutes. Modified golden lysis buffer (20 mM 
Tris [pH 7.9], 137 mM NaCl, 10% glycerol, 1% Triton™ X100, 5 mM EDTA, 
1 mM EGTA, 1 mM Na3VO4, 10 mM NaF, 1 mM sodium pyrophosphate, 0.5 
mM β-glyceroposphate, 1 mM DTT and protease inhibitor cocktail [Roche]) 
was used to solubilize the cells and cell lysates were prepared according to 
Co-IP assay cell lysate preparation as described in section 3.6.  
 Recombinant GST proteins immobilized on glutathione agarose was 
then mixed with either DMSO- or 20 µM PAO-treated FLAG-CasWT 
overexpressed cell lysates and subjected to end-to-end rocking at 4oC for 1 
hour. Next, the mixture was then spun down at 2000 rpm for 5 minutes at 4oC 
and washed with ice cold modified golden lysis buffer, this spinning down and 
washing procedures were repeated twice. Lastly, 2 X sample loading buffer 
was added, mixed thoroughly and denatured at 95oC on a heat block for 5 
minutes. GST pull-down samples were then subjected to SDS-PAGE and 
immunoblot analysis according to section 3.7. 
3.13 Co-immunoprecipitation assay 
Co-immunoprecipitation of FLAG-tagged Cas variants (FLAG-CasWT 
and FLAG-Cas15YF) with Cerulean-tensin 1 was done by co-transfecting 
either FLAG-CasWT or FLAG-Cas15YF and Cerulean-tensin 1 into HEK 
293T cells according to transfection method described in section 3.2. The cell 
lysate preparation was performed by solubilizing the cells with ice cold 
modified golden lysis buffer as previously mentioned in section 3.6.  ANTI-
FLAG M2 Affinity Gel (Sigma-Aldrich®) was used for co-IP assay involving 
FLAG-tagged Cas variants and Cerulean-tensin 1; whereas, PureProteome 
Protein A Magnetic Beads (Millipore) was used to conduct the co-IP assay 
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involving GFP-CasWT and endogenous Src. Both co-IP assays were 
performed according to manufacturers’ instructions.  
ANTI-FLAG M2 Affinity Gel was first resuspended with 1 X TBS 
buffer (50 mM Tris HCl and 150 mM NaCl, pH 7.4) to remove the glycerol in 
the storage buffer. Resuspended resin was then incubated with cell lysates for 
1 hour with continuous end-to-end mixing at 4oC. The immunoprecipitation 
samples were then washed carefully with 1 X TBS buffer after each 
centrifugation steps. Finally, 2 X SDS loading buffer was added to each 
samples, mixed thoroughly and denatured at 95oC for 5 minutes. 
For GFP-CasWT and Src co-IP assay, the magnetic beads suspension 
was first drawn out using clean tip with the tip’s end cut wider. Equivalent 
amount of beads suspension was drawn to make aliquots for the number of 
samples required. Magnetic stand was used with the magnetic beads for all 
washing steps. The magnetic beads were washed with washing buffer (PBS 
containing 0.1% Tween® 20 surfactant). The beads were then re-suspended 
and incubated with smaller amount of the washing buffer and monoclonal 
GFP-antibody (JL8; Clontech) with continuous mixing at room temperature 
for 10 minutes. After 3 washing steps, cell lysates were added to the 
immobilized GFP-antibody on beads and incubated for 1 hour at 4oC with 
continuous end-to-end mixing. The tubes were then placed into the magnetic 
stand, allowed the beads to migrate to the magnet, and then removed the 
sample with a pipette. The samples were then denatured using 2 X sample 
loading buffer after 3 washing steps with the lysis buffer.      
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3.14 Live cell imaging 
All live cell imaging experiments were conducted at Mechanobiology 
Institute (MBI), National University of Singapore. 
3.14.1 Wound healing assay 
Cells were seeded monolayer onto a glass bottom dish (35 mm dish; 
Iwaki®, Japan) and cultured accordingly. When a monolayer of cells was 
formed, a scratch in the middle of the dish was applied using a sterile yellow 
tip. The scratched dish was then subjected to live cell time-lapse phase 
contrast imaging at 10 X magnification. The microscope used was Biostation 
IMQ (Nikon, Tokyo, Japan). Analysis of migration speed was performed 
using ImageJ software (National Institutes of Health [NIH], 
http://rsb.info.nih.gov/ij/) with a manual tracking plug-in. The displacement of 
the nuclei at each time point was drawn. The migration rate was quantified by 
the slope of the plotted points (Machiyama et al., 2014). 
3.14.2 Total Internal Reflection Fluorescence (TIRF)-Fluorescence 
Speckle microscopy (FSM) 
CasKO MEFs stably co-expressing photoactivatable (PA)-GFP-Cas and 
PA-mCherry-actin were transfected with Cerulean-tensin 1-SH2PTB 
according to transfection protocol described in section 3.2. Transfected cells 
were then seeded in a monolayer onto glass bottom dish (35 mm dish; Iwaki®) 
with 10 µg/mL collagen coating. The cells were then subjected to wound 
healing assay as previously described in section 3.14.1. TIRF-FSM was 
performed by using N-STORM Super-Resolution microscope (Nikon) 
equipped with Andor DU897 Electron Multiplying Charge Coupled Device 
(EMCCD) Camera (Andor Technology Ltd, Belfast, UK). Cells were focused 
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with 100 X oil-immersion objective lens (NA 1.49; CFI Plan Apochromat 
TIRF 100XH, Nikon).  Live cell time-lapse imaging was performed by taking 
images continuously for a duration of 30 minutes at 10 second interval. There 
were no time delay between each frame. Photoactivation was done by 
directing laser with 405 nm wavelength to the cell before taking images from 
green and red channels.       
3.14.3 TIRF-Fluorescence Recovery After Photobleaching (FRAP) 
Similarly, TIRF-FRAP experiment was conducted with wound healing 
assay incorporated. Cells were transfected with Cerulean-tensin 1-SH2PTB 
and Cerulean only as control according to transfection protocol previously 
described in section 3.2. Cells were then subjected to wound healing assay 
following the protocol at section 3.14.1. The cells were then subjected to 
Olympus iLas2 TIRF microscope (IX81, inverted microscope, Olympus, 
Tokyo, Japan) equipped with Photometrics Evolve 512 EMCCD camera 
(Photometrics, Tucson, AZ). Objective lens used was oil-immersion UApon 
100X (NA 1.49; TIRF, Olympus). Metamorph software (Molecular Devices, 
Sunnyvale, CA) was used for image acquisition, and ImageJ software (NIH) 
was used for image processing and final figure preparation.  
3.14.4 TIRF-FRAP analysis 
TIRF-FRAP analysis was conducted according to method previously 
published by Machiyama et al. (2014). Fluorescence from individual focal 
adhesions in the leading lamellae was measured and their relative intensity 
against time was plotted. Time zero represented the time when photobleaching 
was terminated. The plots were fitted by equation 1 
[I(t)/I0 = M(1-exp(-t/ τ)) + c]       (1) 
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where I(t) denoted the mean intensity value of individual focal adhesions that 
was normalized against the mean intensity before photobleaching (I0). The 
Mobile fraction (M), time constant (τ), and constant (c) were used as fitting 
parameters. The half-recovery time T1/2 was calculated as; 
[T1/2 = ln(2) x τ ]        (2)   
3.14.4 Confocal microscopy 
Cells were seeded onto glass bottom dish (35 mm; Iwaki®) with 10 
µg/mL collagen coating. Live cell confocal microscopy was performed using 
Nikon A1R confocal microscope (Nikon) equipped with Andor Neo sCMOS 
Camera (Andor Technology Ltd) at 100 X oil-immersion objective lens (NA 
1.40; Plan Apochromat VC, Nikon). 
3.15 Immunofluorescence analysis 
Transfection of Cerulean-tensin1 was done as previously described in 
section 3.2 into CasKO MEFs stably expressing either GFP-CasWT or GFP-
Cas15YF. Transfected cells were then seeded onto glass bottom dish (35 mm 
dish; Iwaki®). The cells were then allowed to spread and subsequently fixed 
with 4% paraformaldehyde (PFA; Sigma-Aldrich®) for 20 minutes and 
permeabilized with 0.5% Triton™ X100 for 4 minutes. Following that, the 
cells were blocked with 1% BSA and 5% FBS dissolved in TBS for 1 hour. 
Primary antibody, anti-phospho-Cas (pCas-165; Cell Signaling Technology) 
was then diluted in TBS in 1:100 dilution factor and then added to the dish for 
incubation at room temperature for 1 hour. Subsequently, the cells were 
washed carefully with 1 X TBS buffer and incubated with pre-diluted 
secondary antibody Alexa Fluor® 546-conjugated goat anti-rabbit IgG 
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(Molecular Probes®, Thermo Fisher Scientific, Inc.) for 1 hour in total dark 
condition. After washing 3 times with 1 X TBS buffer, the dish was mounted 
with ProLong® Gold Antifade Mountant (Molecular Probes®, Thermo Fisher 
Scientific, Inc.) before covered with a coverslip. The immunostained cells 
were then subjected to a confocal microscope (A1R, Nikon) equipped with 
Andor Neo sCMOS Camera (Andor Technology Ltd) at 100 X oil-immersion 
objective lens (NA 1.40; Plan Apochromat VC, Nikon). 
3.16 Total RNA extraction 
Extraction of total RNA from mouse embryonic fibroblasts was 
performed using Takara’s FastPure™ RNA kit. MEFs were cultured on a 60 
mm cell culture dish overnight and harvested according to the user manual. 
Subsequently, the lysate was then homogenized using needle-and-syringe 
method and total RNA was eluted with sterile diethylpyrocarbonate (depc)-
treated MQ water. The purity and quantity of the extracted total RNA was 
determined using NanoDrop 1000 Spectrophotometer. Extracted RNA was 
used immediately for reverse transcription polymerase chain reaction (RT-
PCR) or stored at -80oC. 
3.17 Reverse transcription polymerase chain reaction (RT-PCR) 
First strand complementary DNA (cDNA) was produced when RT-PCR 
was performed by mixing 5 µg of the extracted RNA as template, 100 pmol 
oligo(dT)18, 0.5 mM dNTP mix in 14.5 µL depc-treated water, incubated at 
65oC for 5 minutes and then placed on ice immediately. Four microliters of 5 
X RT buffer, 0.5 µL RiboLock™ Rnase inhibitor, and 1 µL RevertAid™ 
reverse transcriptase (Fermentas, Thermo Fisher Scientific, Inc.) was then 
added and incubated at 50oC for 30 minutes. The reaction was terminated by 
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incubation at 85oC for 5 minutes. The generated cDNA was then used 
immediately for subsequent quantitative real-time PCR of target genes by or 
stored at -30oC. 
3.18 Quantitative real-time PCR 
Quantitative real-time PCR (qPCR) analysis was performed using 
SsoFastTM EvaGreen® Supermix (Bio-Rad Laboratories, Inc.). All 
procedures were performed according to manufacturer’s instruction. The 
reaction condition was set as the following: 30 seconds at 95oC, followed by 
40 cycles of 95oC for 10 seconds and 60oC for 10 seconds using Bio-Rad 
CFX96TM Real-Time PCR Detection System.  The primer set used was: 








































4.1 Tensin 1 associates with Cas depending on the tyrosine 
phosphorylation at Cas substrate domain 
 Tensin 1 harbors a Src homology 2 (SH2) and a phosphotyrosine-binding 
(PTB) domains at its carboxyl-terminus, both of which are reportedly involved 
in the binding to phosphorylated tyrosine-containing polypeptides (Di Stefano 
et al., 2011; Makkinje et al., 2012; Tikhmyanova et al., 2010; Nakamoto et 
al., 1996). We hypothesized that the SH2 and PTB domains of tensin 1 (tensin 
1-SH2PTB) could provide a binding site for Cas with its substrate domain 
(CasSD) phosphorylated. To examine whether tensin 1 bound to Cas 
depending on CasSD phosphorylation, co-immunoprecipitation (co-IP) assay 
was performed.  Either FLAG-tagged wild-type Cas (CasWT) or its 
phosphorylation-defective mutant, Cas15YF, was co-transfected with 
Cerulean-tensin 1 to HEK 293T cells. Cas15YF was created by replacing the 
tyrosine (Y) residues in the fifteen YxxP motifs located in CasSD with 
phenylalanine (F) residues (Kawauchi et al., 2012; Wilkins et al., 1986; 
Machiyama et al., 2014).  The results from our co-IP showed that wild-type 
Cas (CasWT) bound to tensin 1 while this binding was significantly reduced in 
Cas15YF (Figure. 4.1).  Note that Cerulean is a GFP analog and could be 




Figure 4.1 – Tensin 1 associates with Cas in a phosphorylation-dependent 
manner. Either FLAG-CasWT or FLAG-Cas15YF was co-transfected with 
Cerulean-tensin 1 to HEK293T cells. Anti-FLAG immunoprecipitation was 
performed using a M2 Affinity Gel. Immunoblot analysis of the 
immunoprecipitates was conducted using the antibodies indicated.  Note that 
tensin 1 was co-immunoprecipitated with FLAG-CasWT and that the 
association of tensin 1 with FLAG-Cas15YF was reduced compared to that 











4.2 Cas recruits tensin 1 to focal adhesion at cell leading lamellae 
depending on phosphorylation of Cas substrate domain 
The Cas-tensin 1 interaction revealed by biochemical analysis (Figure 4.1) 
prompted us to examine whether Cas spatially associated with tensin 1 in live 
cells. Confocal microscopy allows us to take images at thin slices horizontally 
from the whole cell, and assess the spatial positions of different proteins 
located in a region of interest such as a focal adhesion (McCleverty et al., 
2007). Multi-colours confocal microscopy is based on the simultaneous or 
successive detection of multiple fluorochromes in each individual sample.  
Confocal microscopy incorporated with multi-colours fluorochromes enabled 
us to determine the localization of different fluorescence-tagged proteins 
expressed in the cells’ lowest plane (focal adhesion plane) which are in contact 
with the extracellular matrix (ECM) (Lo et al., 1994).  
Localization of Cas at focal adhesions and its subsequent 
phosphorylation reportedly play an important role in regulating cell migration 
(Lo et al., 1994; Machiyama et al., 2014; Chen and Lo, 2003; Wilkins et al., 
1986). Tensin 1 has also been reported to localize to focal adhesions and 
promote cell migration (Chen et al., 2000; Wavreille and Pei, 2007; Hall et al., 
2009; Saintigny et al., 2008; Nakamoto et al., 1996; Di Stefano et al., 2011; 
Makkinje et al., 2012). We therefore concentrated on the analysis of focal 
adhesions to investigate the spatial interaction between Cas and tensin 1. 
We examined mouse embryonic fibroblasts (MEFs) derived from Cas 
knockout (CasKO) mice (CasKO MEFs)(Honda et al., 1998) stably expressing 
GFP-tagged wild-type Cas (GFP-CasWT) transfected with Cerulean-tensin 1 
using a confocal microscope(Figure 4.2 A and B). At focal adhesion plane, 
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both tensin 1 and Cas were observed at cell lamellipodia (Figure 4.2 A 
Merged). However, when CasKO MEFs expressing GFP-Cas15YF and 
Cerulean-tensin 1, there was no apparent co-localization observed. Notably, 
Cerulean fluorescence from tensin 1 was not seen localized to lamellipodial 
region of the cells (Figure 4.2 B).         
We then examined the co-localization of tensin 1 and phosphorylated Cas in 
cultured cells. To determine the localization of phosphorylated Cas, we 
conducted immunofluorescence staining using an antibody that specifically 
recognizes phosphorylated Cas (pCas-165, Cell Signaling Technology). Using 
a confocal microscope, we visualized the cell-matrix adhesion sites of cells 
immunostained with anti-phospho-Cas (red), fluorescence emissions from 
GFP-tagged Cas variants (GFP-CasWT or GFP-Cas15YF) (green) and 
Cerulean-tensin 1 (blue).  Co-localization of phosphorylated Cas with tensin 1 
at cell lamellipodia was observed in cells expressing GFP-CasWT (Figure. 
4.2C, white). While we observed anti-phospho-Cas staining on GFP-
Cas15YF-expressing cells, there were faint signals perhaps derived from non-
specific binding of the antibody used. Yet, there was no apparent co-
localization of Cerulean-tensin 1 and acti-phospho-Cas staining in GFP-









Figure 4.2 - Cas recruits tensin 1 to focal adhesion at cell leading lamellae 
depending on CasSD phosphorylation. CasKO MEFs stably expressing 
GFP-CasWT or GFP-Cas15YF transfected with Cerulean-tagged tensin 1 were 
subjected to live cell imaging using a confocal microscope. (A) Focal adhesion 
plane of CasKO MEFs expressing GFP-CasWT and Cerulean-tensin 1. A cell 
lamellipodial region (indicated by white rectangles) was analyzed for both 
Cerulean (tensin 1) and GFP (CasWT). Cerulean-tensin 1 was observed co-
localized with GFP-CasWT at the lamellipodia. (B) Confocal images of a 
lamellipodial region (indicated by white rectangles) of CasKO MEFs 
expressing GFP-Cas15YF and Cerulean-tensin 1.  Individual fluorescence and 
merged images are displayed.  Note that Cerulean-tensin 1 is not recruited to 
the lamellipodia.  Scale bar: 50 µm. (C and D) Confocalimages for anti-
phospho-Cas (pCas-165) immunostaining (red), GFP-CasWT or -Cas15YF 
(green) and Cerulean-tensin 1 (blue) at focal adhesions were acquired using a 
confocal microscope. Scale bar: 50 µm.  
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4.3 Cas does not recruit tensin 1 mutant that lacks SH2PTB to focal 
adhesion 
Tensin 1 is known as a focal adhesion protein that binds to actin filaments and 
participates in signaling pathways (Makkinje et al., 2012). It has an extensive 
homology with other tensin family isoforms by sharing several functional 
domains including the Src homology 2 (SH2) and the phosphotyrosine-
binding (PTB) domains at the carboxyl-terminal region (Makkinje et al., 2012; 
Wavreille and Pei, 2007; Hall et al., 2009). The SH2 and PTB domains of 
tensin 1 (tensin 1-SH2PTB) have been reported to bind to tyrosine-
phosphorylated proteins including Cas and FAK (Wavreille and Pei, 2007; 
Donato et al., 2010; Auger et al., 1996; Davis et al., 1991).  
We therefore hypothesized that tensin 1 might bind to phosphorylated 
Cas through the SH2PTB domain, and facilitates the dissociation of Cas from 
focal adhesions. To define the role of the SH2PTB domain of tensin 1 in the 
association with Cas, we tested a tensin 1 mutant that lacks both SH2 and PTB 
domains (tensin 1-ΔSH2PTB). When we analyzed the localization of 
Cerulean-tagged tensin 1-ΔSH2PTB expressed in CasKO MEF stably 
expressing either GFP-CasWT or GFP-Cas15YF,it was not localized to the 





Figure 4.3 - Cas does not recruit tensin 1 mutant that lacks SH2PTB to 
focal adhesion. CasKO MEFs stably expressing GFP-CasWT or GFP-
Cas15YF transfected with Cerulean-tagged tensin 1-ΔSH2PTB were subjected 
to live cell imaging using a confocal microscope. (A) Cnfocal images of 
CasKO MEFs expressing GFP-CasWT and Cerulean-tensin 1-ΔSH2PTB. A 
cell lamellipodial region (indicated by white rectangles) was analyzed for both 
Cerulean (tensin 1-ΔSH2PTB) and GFP (CasWT) fluorescence. The 
individual and merged fluorescence images are shown. No apparent co-
localization of Cerulean-tensin 1-ΔSH2PTB and GFP-CasWT was observed. 
(B) Confocal images of CasKO MEFs expressing GFP-Cas15YF and 
Cerulean-tensin 1-ΔSH2PTB. A cell lamellipodia region (indicated by white 
rectangles)was analyzed. Each individual fluorescence and merged 
fluorescence images are displayed. Cerulean-tensin 1-ΔSH2PTB was not 












4.4 Silencing of tensin 1 impedes cell migration 
The association between Cas and actin cytoskeletons is involved in regulating 
cell migration (Machiyama et al., 2014).  Since we speculated that tensin 1 
might link Cas to actin filaments, we examined the role of tensin 1 in cell 
migration by silencing the endogenous expression of tensin 1 using a retroviral 
shRNA system. After infecting wild-type MEFs with either pSuper vector or 
sh-tensin 1 respectively, antibiotic selection ensued. Continuous treatment 
with antibiotics with appropriate dosages eliminated the cells that were not 
infected, leaving successfully infected cells in the culture to form stable 
expressers of genes of interest. As shown in Figure 4.4 C, we confirmed that 
the introduction of tensin 1 shRNA in MEFs efficiently attenuated the mRNA 
expression level of endogenous tensin 1.  Tensin 1-silenced MEFs was then 
subjected to a wound healing assay to quantitatively analyze their migration. 
Figure 4.4 A shows the representative wound edges of migrating cells 
infected with sh-tensin 1-expressingvirus or pSuper vector control 
immediately, 5 and 10 hours after wounding. Manual tracking the movement 
of individual cell nuclei over the 10 hours revealed that tensin 1-silenced cells 
migrated into the wound significantly slower than the cells infected with the 




Figure 4.4 – Tensin 1 supports cell migration.  MEFs were infected with 
shRNA vector- or tensin 1-shRNA-expressing retroviruses and selected with 
an antibiotic to obtain stable tensin 1-silenced (sh-tensin 1) and control 
(pSuper) cells. Monolayer scratch wounds were generated and cell movement 
was tracked by differential interference contrast (DIC) live cell microscope 
every 10 minutes for 10 hours. (A) Representative images of the control and 
tensin 1-silenced cells at 0, 5 and 10 hours post wounding. Scale bar: 50 µm.  
(B) Cell migration velocities were quantified by tracking and measuring the 
movement of nuclei of individual cells for both the control and tensin 1-
silenced cells. Asterisks indicate p < 0.005 by t-test. (C) Quantitative real-time 
PCR analysis for tensin 1 mRNA expression in the cells infected with the 
pSuper and sh-tensin 1-expressing retroviruses. Relative mRNA levels of 







4.5 Tensin 1-SH2PTB binds to Cas depending on phosphorylation status 
Our co-immunoprecipitaion and co-localization analyses indicated that tensin 
1 and Cas associate at focal adhesions through the SH2PTB domain of tensin 
1 (tensin 1-SH2PTB) (Figure 4.1, 4.2, and 4.3), depending on the 
phosphorylation of CasSD.  We then examined whether tensin 1-SH2PTB 
specifically bound to phosphorylated Cas. To minimize the possible 
involvement of any extraneous tensin 1-binding molecules in the Cas-tensin 1 
association, we conducted a biochemical analysis employing a glutathione S-
transferase (GST) pull-down assay in which bacterially expressed recombinant 
tensin1 SH2 and SH2PTB domain proteins (GST-SH2 and GST-SH2PTB) 
were used. GST-SH2 and GST-SH2PTB proteins were immobilized on 
glutathione agarose beads and incubated with the lysates prepared from 
HEK293T cells expressing FLAG-CasWT, treated with either DMSO or20 
µM phenylarsine oxide (PAO), the tyrosine phosphatase inhibitor (Choquet et 
al., 1997; Janoštiak et al., 2014).  We found that both SH2 and SH2PTB 
proteins bound to FLAG-CasWT in a CasSD phosphorylation-dependent 









Figure 4.5 – Tensin 1-SH2PTB binds to Cas in a CasSD phosphorylation-
dependent manner. GST pull-down assay showed that recombinant GST-
fused SH2 (GST-SH2) and SH2PTB (GST-SH2PTB) proteins bound to 
FLAG-CasWT. (A) Bacterially expressed recombinant GST-fusion proteins 
(GST-SH2, and GST-SH2PTB) and GST only control immobilized on 
glutathione agarose beads were incubated with the lysates prepared from 
HEK293T cells expressing FLAG-CasWT with or without PAO treatment. (B) 
Ten minutes incubation of 20 µM PAO in HEK 293T cells exhibited greatly 










4.6 Tensin 1-SH2PTB expression interferes with Cas-driven cell 
migration 
The results from our GST pull-down assay indicated that tensin 1-SH2PTB 
bound to phosphorylated CasSD (Figure 4.5) which we reported to link 
actomyosin contraction to cell migration (Machiyama et al., 2014). Taken 
together with the previous reports that tensin 1 promotes cell migration (Di 
Stefano et al., 2011; Makkinje et al., 2012), we examined whether the 
SH2PTB domain of tensin 1 played a key role in linking phosphorylated Cas 
to cell motility. To this end, we conducted a wound healing assay using 
CasKO MEFs with and without expression of Cas and tensin-SH2PTB. After 
infecting the CasKO MEFs, which either express mCherry-Cas or not, with 
GFP only- or GFP-tensin 1-SH2PTB-transducing adenovirus, cell monolayers 
were scratched to stimulate their migration and subjected to phase contrast live 
cell imaging for 10 hours post wounding. Representative images of wound 
edges at 0, 5 and 10 hours were shown in Figure 4.6 A. Introduction of 
mCherry-Cas in CasKO MEFs control cells (non transduced and GFP only) 
significantly increased cell migration (comparing non-transduced CasKO 
MEFs and CasKO-mCherryCas MEFs in Figure 4.6 A). While the 
expression of GFP-SH2PTB significantly slowed down the migration of both 
CasKO MEFs and CasKO-mCherry-Cas MEFs, this was more prominent in 
the latter (CasKO-mCherry-Cas MEFs) (Figure 4.6 B).  These results suggest 
that the expression of the SH2PTB domain has as a ‘dominant-negative’ effect 
on the binding between phosphorylated Cas and endogenous tensin 1, thereby 
impeding cell migration. The interference with cell motility by the expression 
of tensin 1-SH2PTB supports the significant role of the phosphorylation-
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dependent Cas-tensin 1 association. Figure 4.6C showed the expression levels 






Figure 4.6 – Tensin 1-SH2PTB interferes with Cas-driven cell migration. 
Wound healing assays were conducted using adenoviral-transduced CasKO 
MEFs or CasKO-mCherry-Cas MEFs. GFP only or GFP-SH2PTB was 
transduced into CasKO MEFs or CasKO-mCherry-Cas MEFs. A monolayer 
scratch was introduced to stimulate migration and cells were viewed over 10 
hours by live DIC microscopy. (A) Representative images of the cells 
expressing either GFP only, GFP-SH2PTB at 0, 5 and 10 hours post 
wounding. Non-transduced control cells were also shown. Scale bar: 50 µm. 
(B) Cell migration velocities were quantified by manually tracking the 
movement of individual cells’ nuclei over 10 hours post wounding. (C) 
Immunoblots showed the expression levels of GFP or GFP-SH2PTB after 
adenoviral transduction. The anti-β-actin blot provided a loading control in 
this immunoblot analysis. 
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4.7 Tensin 1-SH2PTB expression stabilizes Cas residence at focal 
adhesions 
We hypothesized that tensin 1 would bind to phosphorylated Cas at focal 
adhesion through its SH2PTB domain and link retrograding actin filament 
with its actin-binding domain, thus facilitating the dissociation of 
phosphorylated Cas from focal adhesion. Diminishing the linkage between 
Cas and filamentous actin might interfere with the displacement of 
phosphorylated Cas from focal adhesion. We therefore examined whether the 
mobility of Cas at focal adhesions was modulated by the exogenous 
expression of tensin 1-SH2PTB that lacks the actin-binding domain, expecting 
a dominant-negative effect against endogenous tensin 1. 
To analyze the effect of the exogenous expression of tensin 1-SH2PTB 
in cells, we conducted total internal fluorescence reflection (TIRF) microscopy 
combined with the fluorescence recovery after photobleaching (FRAP) 
(Machiyama et al., 2014). This TIRF-FRAP technique allowed us to 
exclusively analyze the events on the lowest plane of adherent cells (<100 nm 
from the surface of the glass-bottom dish) where focal adhesion complexes are 
located(Ridley et al., 2003; Machiyama et al., 2014). Furthermore, the TIRF-
FRAP also managed to selectively photobleach fluorescent proteins attached 
to the Cas proteins localized at focal adhesions but not those in the cytosol 
(Machiyama et al., 2014). CasKO MEFs stably expressing GFP-CasWT 
transfected with Cerulean-tensin 1-SH2PTB were seeded onto a glass-bottom 
dish in a monolayer. To stimulate cells migration, the monolayer of cells was 
scratched (Meenderink et al., 2010). Photobleaching was done by increasing 
the laser power with the region of interest (ROI) set at the leading lamellipodia 
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of the migrating cell. We then analyzed the recovery of fluorescence emitted 
from the fluorescent protein tagged to CasWT at individual focal adhesions 
located in the leading lamellae of migrating cells during the wound closure. In 
this study, fast fluorescence recovery indicates the high turnover rate of Cas at 
focal adhesion, and vice versa. The fluorescence recovery of GFP-tagged Cas 
was significantly encumbered by the expression of tensin 1-SH2PTB (Figure 
4.7 A and B). When mobile fraction (M) and half-recovery time (T1/2) were 
calculated from the fluorescence recovery curves (Figure 4.7 B), the 
expression of tensin 1-SH2PTB led to a significant increase in T1/2 as well as a 
significant decrease in M (Figure 4.7 C and D). These results suggested that 
the expression of tensin 1-SH2PTB stabilized Cas residence at focal 




Figure 4.7 - Tensin 1-SH2PTB expression stabilizes Cas residence at focal 
adhesions. (A) Representative FRAPs of GFP-tagged Cas molecules 
expressed in migrating CasKO MEFs are presented as pseudocolor images 
before (Pre-bleach), immediately (0 s), 15 s, 30 s, 40 s, and 60 s after 
photobleaching. Pseudocolors correspond to the mean fluorescence intensities 
of individual focal adhesions normalized against their mean fluorescence 
intensity before photobleaching. Scale bar: 1 µm. (B) Mean fluorescence 
intensities I(t)/I0 of individual focal adhesions are plotted against time (from 
immediately after photobleaching up to 60 seconds) for GFP-CasWT. (C) 
Mobile fraction, M and (D) half-recovery time, T1/2 were obtained from 
equations 1 and 2 (see materials and methods section 3.14.4). Asterisks 




4.8 Tensin 1-SH2PTB expression does not affect paxillin turnover at 
focal adhesions 
While focal adhesion is a complex consisting of many different proteins, we 
examined the specificity of the effect of the exogenous expression of tensin 1-
SH2PTB by testing the dynamics of another focal adhesion protein.  
Paxillin has been well-recognized as a focal adhesion as well as a 
mechano-sensitive protein in mammalian cells (Wilson et al., 2014; Polacheck 
et al., 2014; Gawlak et al., 2014; German et al., 2014). Because the 
subcellular localization of paxillin is mainly at focal adhesions, we chose it as 
a control protein for our TIRF-FRAP analysis. CasKO MEFs stably 
expressing paxillin-mCherry were transfected with Cerulean-tensin 1-
SH2PTB, and subjected to a wound healing assay. The TIRF-FRAP analysis 
was conducted on cell monolayers after a scratch introduction. As in the 
observation of mCherry-Cas, the fluorescence recovery of paxillin-mCherry at 
individual focal adhesion was monitored. We found that the recovery of 
fluorescence from paxillin-mCherry was not affected by the expression of 
tensin 1-SH2PTB (Figure 4.8 A and B). When both mobile fraction (M) and 
half-recovery time (T1/2) from the fluorescence recovery curves (Figure 4.8 B) 
were calculated, there were no significant effects of the expression of tensin 1-
SH2PTB on the turnover rate of paxillin at focal adhesions (Figure 4.8 C and 
D). These results suggest that the turnover rate of paxillin at focal adhesions is 
not affected by the expression of tensin 1-SH2PTB, inferring that the retarding 
effect of tensin 1-SH2PTB expression on molecular turnover at focal 





Figure 4.8 – Tensin 1-SH2PTB expression does not affect paxillin 
turnover at focal adhesions. (A) Representative FRAPs of mCherry-tagged 
paxillin molecules expressed in migrating CasKO MEFs are presented as 
pseudocolor images before (Pre-bleach), immediately (0 s), 15 s, 30 s, 40 s, 
and 60 s after photobleaching. Pseudocolors correspond to the mean 
fluorescence intensities of individual focal adhesions normalized against their 
mean fluorescence intensity before photobleaching. Scale bar: 1 µm. (B) Mean 
fluorescence intensities I(t)/I0 of individual focal adhesions are plotted against 
time (from immediately after photobleaching up to 60 seconds) for paxillin-
mCherry. (C, D) Mobile fraction, M (C) and half-recovery time, T1/2 (D) were 
obtained from equations 1 and 2 (see materials and methods section 3.14.4).  
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4.9 Tensin 1-SH2PTB stabilizes Cas on focal adhesion 
We previously found that the inward movement of Cas molecules was 
correlated with the myosin-driven actin retrograde flux that promoted focal 
adhesion disassembly and cell migration (Machiyama et al., 2014). In our 
present study, we took advantage of photoactivatable fluorescent proteins that 
allowed us to visualize the intracellular molecular dynamics and protein 
localization with superresolution microscopy (Piatkevich and Verkhusha, 
2010). We used Cas tagged with photoactivatable type of GFP (PA-GFP-Cas) 
to track the movement of Cas molecules, and photoactivatable mCherry-actin 
(PA-mCherry- actin) to monitor the retrograde flow of actin at the focal 
adhesions in the lamellipodial regions. In such a way, TIRF-FSM technique 
was employed as photoactivated fluorescent molecule cluster movement can 
be visualized at cell's focal adhesion plane.  
 A stable expression of PA-GFP-Cas and PA-mCherry-actin in CasKO 
MEFs was established by retroviral infection. After being transfected with 
Cerulean-tensin 1-SH2PTB or Cerulean only as a control, the cells were then 
seeded in a monolayer and scratched to stimulate their migration. Using a live-
cell TIRF microscope, the movements of Cas and actin molecules at the 
leading lamellae of migrating cells were traced. The time-lapse imaging of the 
control cells (CasKO MEFs expressing PA-GFP-Cas and PA-mCherry-actin, 
transfected with Cerulean only) showed no obvious or traceable localization of 
PA-GFP-Cas on the focal adhesion plane (Figure 4.9 A and B). This suggests 
that Cas molecules do not reside stably at focal adhesions, consistent with the 
quick turnover of Cas molecules that we previously reported (Machiyama et 
al., 2014). In contrast, the live-cell TIRF time-lapse imaging of the cells 
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expressing Cerulean-tensin 1-SH2PTB managed to visualize Cas movement 
on the focal adhesion plane (Figure 4.9 C and D). Collectively, these results 
suggest that tensin 1-SH2PTB stabilizes Cas residence at focal adhesions, 
conforming to its dominant-negative effect on the association between 
phosphorylated Cas and endogenous tensin 1 that facilitates the displacement 


















Figure 4.9 – Tensin 1-SH2PTB expression stabilizes Cas at focal adhesion. 
TIRF-FSM was performed to visualize both actin flux and Cas movement in 
the cells with or without the expression of tensin 1-SH2PTB. CasKO MEFs 
expressing PA-GFP-Cas and PA-mCherry-actin, transfected with either 
Cerulean only or Cerulean-tensin 1-SH2PTB, were subjected to a wound 
healing assay. The lamellipodial regions were analyzed by the time-lapse 
TIRF-FSM imaging.(A) Representative images of the migrating cells 
transfected with Cerulean only. Scale bar: 50 µm. (B) Kymographs drawn on 
the movement of actin and Cas molecules along the white dashed line in (A). 
The arrows represent the retrograde movement of actin and Cas clusters. 
Vertical scale: 5 minutes; horizontal scale: 2 µm. (C) Representative images 
extracted from the videos of the migrating cells transfected with Cerulean-
tensin 1-SH2PTB. Scale bar: 50 µm. (D) Kymographs drawn for the 
movement of actin and Cas molecules along the white dashed line in (C). The 
arrows represent the retrograde movement of actin and Cas clusters. Vertical 











4.10 PAO treatment reinforces the correlation between actin flux and Cas 
movement 
In this study, we test tensin 1 as a molecule that links phosphorylated Cas to 
actin cytoskeletons, thereby facilitating the dissociation of Cas molecules from 
adhesion complexes. We therefore examined whether the inhibition of 
dephosphorylation of Cas reinforced the correlation between actin flux and 
Cas movement and modulated the Cas turnover at focal adhesions. To this 
end, we used a low dose (5 nM) of PAO, which reportedly modulates the 
molecular dynamics of focal adhesion proteins without significantly affecting 
the inward actin flux and the lamellipodial morphology. We found that the 
movement of PA-GFP-Cas was traceable in the TIRF-FSM in the cells treated 
with 5 nM PAO (Figure 4.10 A and B), suggesting the residence of Cas 
molecules is stabilized by the inhibition of Cas dephosphorylation.  
Although the expression of tensin 1-SH2PTB also stabilized Cas at 
adhesion sites (Figure 4.9 C), the movements of Cas and actin molecules were 
poorly correlated in the tensin 1-SH2PTB-expressing cells (see the 
inclinations of arrows in Figure 4.9 D). By contrast, the movements of Cas 
and actin molecules appeared more correlated when cells were treated with 5 
nM of PAO (see the inclinations of arrows in Figure 4.10 A and B), 
supporting the reinforced association between Cas and actin cytoskeletons 








Figure 4.10 –Low dose PAO treatment enhances the correlation between 
the movements of actin and Cas molecules. TIRF-FSM was performed to 
visualize the movements of both actin and Cas molecules. CasKO MEFs 
expressing PA-GFP-Cas and PA-mCherry-actin with transient transfection of 
Cerulean only were subjected to a wound healing assay. The lamellipodial 
regions of migrating cells were analyzed by the time-lapse TIRF-FSM 
imaging. (A) Representative images extracted from the videos of the migrating 
cells treated with 5 nM PAO. Scale bar: 50 µm. (B) Kymographs drawn on the 
movement of actin and Cas molecules along the white dashed line in (A) in the 
cells were generated. The arrows represent the retrograde movement of actin 


















4.11 Low dose of PAO treatment weakens the Cas-Src association 
We have recently reported that the association-dissociation dynamics between 
Cas and Src at focal adhesion sites is crucial in the regulation of cell migration 
(Machiyama et al., 2014). We showed that Cas molecules were tethered to the 
adhesion complexes based through the binding to Src, while they were 
displaced from focal adhesions through the association with actin 
cytoskeletons following CasSD phosphorylation. Since these two elements, 
i.e. tethering to and displacement from adhesions, appeared to oppose each 
other in terms of Cas turnover, we examined whether the Src-Cas association 
was modulated by 5 nM PAO treatment, which strengthened the actin-Cas 
correlation (Figure 4.10). When we conducted a co-IP analysis on CasKO 
MEFs expressing either GFP only or GFP-Cas, we observed that the 
association between and Src and GFP-Cas was weakened in the cells treated 
with 5 nM PAO (Figure 4.11 A). In addition, Src was poorly co-
immunoprecipitated with GFP only whether or not cells were treated with 5 
nM PAO (Figure 4.11 A), and the analysis on the whole cell lysate showed 
consistent endogenous Src expression (Figure 4.11 B).These results suggest 
that the Src-Cas association is weakened upon the inhibition of Cas 
dephosphorylation. Our findings from the co-IP experiments also support the 
above-mentioned notion that the actin-Cas correlation is reinforced by the 
inhibition of Cas dephosphorylation. Interestingly, we did not observe a 
significant increase in CasSD phosphorylation in the cells treated with 5 nM 
PAO (Figure 4.11 B). We speculate that the decreased Src-Cas association 
after 5 nM PAO treatment gave rise to the attenuated CasSD phosphorylation 




Figure 4.11 – Low dose PAO treatment weakens the Cas-Src association. 
Co-immunoprecipitation assay was conducted to examine the association of 
Cas and Src. CasKO MEFs stably expressing either GFP only or GFP-CasWT 
was treated with 5 nM PAO for 2 hours before cell lysis followed by anti-GFP 
immunoprecipitation. DMSO was used as a control for PAO. (A) Immunoblot 
analysis of anti-GFP immunoprecipitates using the antibodies as indicated; IB: 
GFP, IB: Src and IB: Phospho-Cas. (B) Immunoblot analysis ofthe whole cell 
lysate before immunoprecipitation was conducted. Equivalent portions of cell 
lysates were subjected to SDS-PAGE followed by immunoblotting using the 
antibodies indicated; IB: GFP, IB; Src, IB: Phospho-Cas and IB: -actin. 




4.12 Low dose of PAO impedes cell migration 
We have shown that PAO at its low concentration weakens the Cas-Src 
association (Figure 4.11). Furthermore, we have reported that stabilization of 
Cas-Src association at focal adhesions impeded Cas displacement from focal 
adhesion, thereby impeding cell migration (Machiyama et al., 2014). On the 
other hand, we demonstrate that 5 nM PAO treatment weakens the Cas-Src 
association at focal adhesion (Figure 4.10 and 4.11). However, when we 
conducted a wound healing assay to examine the effect of 5 nM PAO 
treatment on cell motility, it significantly decreased the migration rate (Figure 
4.12 A and B). These results suggest that the dynamic turnover of Cas 
molecules at focal adhesions based on both the Src-binding-dependent 






Figure 4.12 – 5 nM PAO treatment impedes cell migration. Wound healing 
assays were conducted using CasKO stably expressing GFP-CasWT MEFs 
with and without 5 nM PAO treatment. DMSO was added to the culture 
medium as a control. A monolayer scratch was introduced to stimulate 
migration, and the cells were imaged over 10 hours by a live-cell phase-
contrast microscope. (A) Representative images of cells treated with either 
DMSO or 5 nM PAO at 0, 5 and 10 hours post wounding. Scale bar: 50 µm. 
(B) Cell migration velocities were quantified by manually tracking the 
movement of the nuclei of individual cells over 10 hours post wounding. 






4.13 PAO does not affect the movement of Cas molecules in the cells 
expressing tensin 1-SH2PTB 
Our results showed that the exogenous expression of tensin 1-SH2PTB 
stabilized Cas residence at focal adhesions (Figure 4.9), and we speculated 
that this was due to the disruption of the correlation between actin 
cytoskeletons and Cas molecules. We then examined whether 5 nM PAO 
treatment modulated the dynamics of Cas molecules at focal adhesions of cells 
expressing tensin 1-SH2PTB. As shown in Figure 4.13 A and B, we did not 
observe any significant effect of PAO on the movement of either PA-GFP-Cas 
or PA-mCherry-actin molecules expressed in migrating CasKO MEFs 
transfected with Cerulean-tensin 1-SH2PTB (compare with Figure 4.9 C and 
D). These results agree with the notion that the PAO treatment reinforces Cas-
actin correlation in which tensin 1 plays an important role through the binding 













Figure 4.13 –5 nM PAO does not affect the movement of Cas molecules in 
the cells expressing tensin 1-SH2PTB. TIRF-FSM was performed to 
visualize both actin flux and Cas inward movement in the cells treated with 5 
nM PAO. CasKO MEFs stably expressing PA-GFP-Cas and PA-mCherry-
actin were transfected with Cerulean-tensin 1-SH2PTB,and subjected to a 
wound healing assay. The lamellipodial regions of the migrating cells were 
analyzed by the time-lapse TIRF-FSM imaging. (A) Representative images 
extracted from the videos recording the PAO (5 nM)-treated migrating cells 
expressing Cerulean-tensin 1-SH2PTB. Scale bar: 50 µm. (B) Kymographs 
drawn for the movement of actin and Cas along the white dashed line in (A). 
The arrows represent the retrograde movement of actin and Cas clusters. 











































5.1 Cas and tensin 1 association regulates cell migration 
Cell migration is a cellular behavior involved in various important biological 
events including morphogenesis, tissue repair and immune response (Yumura 
et al., 2013). It is a highly dynamic process whereby numerous cell signaling 
cues are integrated to generate a coordinated response (Meenderink et al., 
2010). These fundamental cell functions involve various microcellular 
regulatory machineries that assist cells to react to diverse external stimuli. The 
molecular mechanisms underlying the cell migration have been extensively 
studied due to their relevance to vital physiological processes, such as 
immunological reactions, tumor metastasis/invasion, embryonic development, 
and wound healing (Di Stefano et al., 2011).   
Focal adhesion proteins have been demonstrated to have significant 
impacts on cell migration (Di Stefano et al., 2011). The adaptor protein Cas, 
apart from its role as a signal convergence platform in focal adhesion 
complexes, functions as a cytoskeletal mechano-sensor through the stretch-
dependent substrate domain (CasSD) tyrosine phosphorylation (Wilkins et al., 
1986).  In this study, we focus on the identification of a protein that supports 
cell migration by temporally linking actin cytoskeletons to Cas with 
phosphorylated CasSD. We reveal the mechanism by which actomyosin 
contraction displaces phosphorylated Cas from focal adhesions. We 
demonstrate that tensin 1, which harbors both an actin-binding and a 
phosphotyrosine-binding domain, drives cell migration through the association 
with phosphorylated Cas and actin cytoskeletons at focal adhesions. 
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5.2 Displacement of Casmolecules from focal adhesions links 
actomyosin contraction to cell migration 
We have previously reported that Cas supports cell migration through the 
association with Src and actomyosin contraction at focal adhesions 
(Machiyama et al., 2014). When cells migrate, Cas molecules diffusely 
distributed in the cytosol are recruited to focal adhesions where they bind to 
Src through the Src-binding domain (CasSB) (Machiyama et al., 2014; 
Meenderink et al., 2010), and the substrate domain (CasSD) is subsequently 
tyrosine phosphorylated (Wilkins et al., 1986; Chen and Lo, 2003). CasSD 
phosphorylation has been implicated in various cell functions such as 
migration, invasion, metastasis and differentiation (Brábek et al., 2005; Shin et 
al., 2004; Kawauchi et al., 2012). CasSD provides a platform for the 
formation of signaling complexes at focal adhesions, many of which involve 
actin cytoskeletons. Continuous actin inward flux exerts pulling force to the 
molecular complex including Cas, displacing them from the adhesion sites 
(Machiyama et al., 2014). To oppose such an inward traction force exerted on 
Cas molecules, Src temporally tethers Cas to the adhesion complexes and 
constitutes a cytoskeleton-adhesion linkage. This appears to be a highly 
dynamic process, as genetic engineering-based stabilization of Src-Cas 
association using bimolecular fluorescence complementation (BiFC) technique 
(Hu et al., 2002) led to a significant retardation of cell migration (Machiyama 





5.3 Role of actomyosin contraction in adhesion dynamics and cell 
migration 
Cell migration requires the transmission of cell-generated force to the 
extracellular environment through focal adhesion complexes formed at the 
cell-matrix contact sites (Hu et al., 2007). A coordinated spatiotemporal 
orchestration of cell protrusion at the leading edge, adhesion complexes 
formation and retraction of the weakened adhesion at the rear drives cell 
advancement (Hu et al., 2007; Meenderink et al., 2010). Both actin and 
myosin II play pivotal roles in cell migration by exhibiting a rapid turnover as 
cell moves (Yumura et al., 2013). The migrating cells typically extend 
lamellipodia in the anterior (Prass et al., 2006; Yumura et al., 2013; Yumura, 
2001). The coupling of actin-related protein (Arp)-2/3-mediated actin 
polymerization at the anterior edge of cells with actin-depolymerizing factor 
(ADF)/cofilin-mediated depolymerization of actin filaments at the rear keeps 
the overall length of actin filaments constant (Machesky and Insall, 1998; 
Pantaloni et al., 2001; Small et al., 2002; Pollard and Borisy, 2003; Yumura et 
al., 2013). Monomeric actin subunits exchange at the leading edge and move 
towards the rear in a treadmilling process that does not alter the overall length 
of the protrusion (Yumura et al., 2013; Wang, 1985). Simultaneously, actin 
filaments that polymerize at the cell leading edge often flow backwards as the 
cell migrates in a process termed “retrograde flow” (Brown et al., 2006; Hu et 
al., 2007; Guo and Wang, 2007; Yamashiro et al., 2014). Previous studies 
have revealed that this actin retrograde flow is not solely driven by actin 
polymerization but also by myosin II activity (Henson et al., 1999; Ponti et al., 
2004; Renkawitz et al., 2009; Yumura et al., 2013).  
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Recently, the inhibition of actin polymerization, but not of myosin II , 
has been reported to down-regulate Cas phosphorylation (Chen and Lo, 2003; 
Hotta et al., 2014). We have previously reported that actomyosin-driven 
displacement of Cas molecules from focal adhesion sites depends upon their 
phosphorylation and accelerates cell migration (Machiyama et al., 2014). 
Tyrosine phosphorylation of CasSD catalyzes series of downstream 
signaling pathways which lead to enhance cell migration. For instance, the 
Crk/DOCK180/Rac signaling pathway that is activated upon CasSD 
phosphorylation plays a central role in the activation of Pak1, which 
reportedly contributes to the increased rates of both focal adhesion turnover 
and cell migration (Hsia et al., 2003; Delorme-Walker et al., 2011; Chen and 
Lo, 2003; Machiyama et al., 2014).  In addition, the inhibition of actomyosin 
contraction exhibit impeded cell migration, consistent with our and others’ 
previous observations (Hopkins et al., 2007; Ivkovic et al., 2012; Machiyama 
et al., 2014). Moreover, maturation of focal adhesions largely relies on 
actomyosin-based contractile force, while contractility-dependent 
phosphorylation of FAK and paxillin facilitates disassembly of focal 
adhesions at cell front which is a process central to cell migration (Pasapera et 
al., 2010; Webb et al., 2004). These variations reported with regards to the 
role of actomyosin contraction in turnover dynamics of focal adhesions may 
derive from the differences in cell types including those related to malignancy 




5.4 Tensin 1 links inwardly moving actin filaments and Cas at focal 
adhesion complexes 
Cell migration involves a coordinated and dynamic recycling of focal adhesion 
proteins at the leading edge (Ridley et al., 2003). To further dissect the 
mechanisms involved in cell migration at a subcellular level, we investigated 
how Cas molecules undergo turnovers at focal adhesions.  
 In our present study, we seek the molecule that supports the 
displacement of Cas from adhesion complexes by linking inwardly moving 
actin cytoskeletons to phosphorylated Cas. In order to form a molecular 
complex that mediates this process, the molecule needs to be able to bind to 
both phosphorylated Cas and filamentous actin simultaneously. Seeking the 
candidates that meet this requirement, we have consolidated previous reports 
and identified tensin 1, an actin-binding molecule that has been implicated as a 
phosphorylation-specific binding partner of Cas (Clark et al., 2010; Lo, 2007; 
McCleverty et al., 2007; Hall et al., 2010; Chen and Lo, 2003; Lo et al., 
1994). Here we show that tensin 1 transmits actomyosin contractility to 
adhesion sites by temporally binding to phosphorylated Cas, thereby providing 
a clutch that reconciles the continuously moving cytoskeletons with the 
stationary adhesion complexes and supports cell migration.  
 The function of tensin 1 as a potential link between the cytoskeleton 
and signal transduction has been discussed previously. Lo et al. (1994) have 
proposed that cytoskeletal proteins only maintain structural integrity of cells 
but also associate with signal transduction. At focal adhesion sites, the ECM 
has a close contact with the cell through various proteins that are localized at 
the ventral cell surface and connected with the cytoskeletal elements, namely 
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actin filaments (Lo et al., 1994). These focal adhesion proteins have attracted 
attention of many researchers since they appear to play a crucial role in signal 
transduction.  
 Tensin 1 is an actin- and phosphotyrosine-binding protein which 
localizes to focal adhesions (Di Stefano et al., 2011). It has also been reported 
to bind to or co-immunoprecipitate with Cas in vitro (Wavreille and Pei, 2007; 
Cui et al., 2004; Donato et al., 2010). The SH2 and PTB domains located at 
the carboxyl-terminus of tensin 1 (tensin 1-SH2PTB) have been shown to bind 
to Cas upon CasSD phosphorylation at focal adhesions (Wavreille and Pei, 
2007; Leone et al., 2008; Nakamoto et al., 1996; Di Stefano et al., 2011; Lo et 
al., 1994; Lo et al., 1994; Wavreille and Pei, 2007). We demonstrate that 
tensin 1 associates with Cas depending upon CasSD phosphorylation by co-IP 
and immunostaining analyses (Figure 4.1 A and 4.2 CD).  By contrast, no 
apparent co-localization was observed between tensin 1 and the 
phosphorylation-defective mutant of Cas, Cas15YF (Figure 4.2 B). This 
suggests that CasSD phosphorylation is important to a form molecular 
complex involving tensin 1. Furthermore, the silencing of tensin 1 in MEFs 
significantly retards cell migration velocity (Figure 4.4).  Reduced expression 
of tensin 1 gives rise to a decrease in the tensin 1-Cas molecular complex 
formation and down-regulates the displacement of Cas from focal adhesions, 
thereby impeding the cell migration. When tensin 1 mutant that lacks the SH2 
and PTB domains was expressed in the CasKO MEFs expressing either wild-
type Cas or Cas15YF, no co-localization was observed in the cell lamellipodia 
(Figure 4.3 A and B). These findings strongly supports the notion that Cas 
and tensin 1 associate with each other through the binding between tyrosine-
87 
 
phosphorylated CasSD and the phosphotyrosine-binding domain of tensin 1 
(tensin 1-SH2PTB).  
 
5.5 Dominant-negative effect of the exogenous expression of a 
truncation mutant of tensin 1, tensin 1-SH2PTB 
Tensin 1-SH2PTB appeared to be the putative binding site for Cas with 
phosphorylated CasSD at focal adhesions. We therefore introduced a 
truncation mutant that harbors SH2PTB but lacks the other regions of tensin 1, 
including the actin-binding domains. This mutant was supposed to bind to 
phosphorylated Cas but not to displace Cas from adhesion complexes. As 
expected, the exogenous expression of tensin 1-SH2PTB affected the turnover 
dynamics of Cas molecules at focal adhesion (Figure 4.7) and retarded cell 
migration (Figure 4.6). These findings indicate that the exogenous expression 
of tensin 1-SH2PTB has a dominant-negative effect for the endogenous tensin 
1, conforming to the role of tensin 1 as a link between actin cytoskeletons and 
phosphorylated Cas at focal adhesions.  
Cas and tensin 1 appeared to associate through the binding between 
CasSD and tensin 1-SH2PTB. Nonetheless, it was unclear whether tensin 1-
SH2PTB directly bound to phosphorylated CasSD. In our GST pull-down 
experiments (Figure 4.5), we used bacterially expressed recombinant GST-
tensin 1-SH2PTB proteins to exclude the involvement of extraneous tensin 1-
associating molecules in the binding to Cas. Since FLAG-CasWT that we used 
in our GST pull-down experiments was expressed in HEK 293T cells, we 
cannot completely preclude the possibility that tensin 1-SH2PTB associates 
with Cas through a phosphorylated CasSD-binding protein that is still 
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unidentified. However, from the high expression level of FLAG-CasWT 
transfected to HEK 293T cells, the in vitro binding GST-tensin1-SH2PTB and 
FLAG-CasWT that we observed (Figure 4.5 A) is likely to represent their 
direct binding.  
 Live cell TIRF-FRAP imaging analyses revealed that the residence of 
Cas molecules at focal adhesions extended in cells exogenously expressing 
tensin 1-SH2PTB (Figure 4.7). This was not a non-specific effect of the 
exogenous expression of tensin 1-SH2PTB, because it did not apparently 
modulate the turnover of paxillin, another well-recognized focal adhesion 
protein (Figure 4.8).  
Using the TIRF-FSM technique, we were able to trace the movement 
of Cas molecules in the cells exogenously expressing tensin 1-SH2PTB 
(Figure 4.9 B). In contrast, PA-GFP-Cas only appeared as a blinking 
fluorescence on the focal adhesion plane, and we were unable to draw a 
kymograph on the movement of Cas molecules in the control cells (Figure 4.9 
A). Considering the frequency of image acquisition in these analyses (every 10 
seconds), this was consistent with the rapid turnover of Cas molecules at focal 
adhesions that we and others previously described (Machiyama et al., 2014; 
Carisey et al., 2013).  
 
5.6 PAO stabilizes the molecular complex formed between 
phosphorylated Cas and tensin 1 
Although the treatment with the tyrosine phosphatase inhibitor, PAO has been 
shown to lead to increased phosphorylation of Cas  (Figure 4.5 B) (Janoštiak 
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et al., 2014; Stover et al., 1991), it also has numerous off-target effects 
including the attenuation of action retrograde flux when used in a 
concentration that is commonly employed to efficiently inhibit tyrosine 
dephosphorylation (e.g. 20 μM). However, low dose (5 nM) of PAO has been 
reported not to affect lamellipodia morphology and cytoskeleton movement 
(Choquet et al., 1997). When we tested 5 nM PAO, the tyrosine 
phosphorylation status of CasSD was not significantly altered. Nonetheless, 5 
nM PAO appeared to strengthen the Cas-tensin 1-actin linkage while it 
appeared to weaken the Cas-Src association (Figure 4.11). We speculate that 
the unaltered phosphorylation status of CasSD after 5 nM PAO treatment 
(Figure 4.11 B) resulted from the offset between the phosphatase inhibition 
(i.e., decreased dephosphorylation) and the attenuated Src-Cas association 
(decreased phosphorylation). 
Despite the unchanged CasSD phosphorylation, 5 nM PAO treatment 
significantly retarded cell migration (Figure 4.12).  These findings feature the 
importance of dynamic interaction between Cas, Src and tensin 1, rather than 
biochemical status (e.g. phosphorylation) of individual molecules, in the 
regulation of cell motility.  
 
5.7 Conclusion 
From the findings that we have obtained through our extensive studies, we 
conclude that tensin 1 is the molecule that links inwardly moving actin 
cytoskeletons to phosphorylated Cas at focal adhesions, thereby supporting 
cell migration. Based on the temporal nature of Src-Cas and Cas-tensin 1 
associations, the actin-tensin 1-Cas-Src linkage could serve as a molecular 
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clutch that reconciles motile and stationary parts of the cell locomotive 
machinery.  
 
5.8 Future study 
We have demonstrated that the dynamic interaction between Src, Cas, and 
tensin 1 is crucial for transmission of actomyosin contraction to cell-matrix 
contact sites. However, because of time limitation, we have not tested the role 
of this molecular complex in the transduction of cell-generated forces.  As a 
next step of our study, we plan to quantitatively analyze the forces that cells 
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